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Antibodies form an essential component of the adaptive immune system, but they also have important
scientific and clinical applications. These applications exploit the proven ability of antibodies to bind strongly
and specifically to nearly any biomolecular target (e.g. protein) of interest. To produce antibodies for scientific
and clinical applications, researchers can use a wet-lab technique called antibody phage display. Antibody
phage display starts with a library of diverse antibody fragments and selects and amplifies those fragments
that bind to the target. Antibody phage display combined with next-generation sequencing (NGS) technology
has the potential to yield greater insight into the selection process.
Machine learning is an area of artificial intelligence uniquely suited to recognizing patterns in large
datasets, like those produced by NGS.
The research goals of this thesis were to (1) train machine learning models to predict the selection of
antibody fragments in antibody phage display using only the sequence of the fragment; (2) validate the
ability of the trained models to generalize to different experiments; and (3) reverse engineer the trained
models to gain greater insight into the learned patterns and the selection process.
Antibody phage display data produced by the Geyer lab (University of Saskatchewan, SK) using two
libraries called F and S was used to train a set of machine learning models: naive Bayes network (NB), linear
model (LM), artificial neural network (ANN), support vector machine (SVM) with a radial basis function
kernel (RBF-SVM), a SVM with a string kernel (SSK-SVM), and a random forest (RF). In addition, key
parameters of the RBF- and SSK-SVM were tuned using a gridsearch. The trained models were then used
to predict which antibody-displaying phage would be observed after the 5th round of panning, and their
prediction accuracy on this data was used to help select models for subsequent analyses. The models selected
were the RBF- and SSK-SVM. To achieve the second research goal, data originating from library F was used
to train the two SVMs while library S data was used to test them. Finally, the two SVM models trained on
library F were deconstructed to understand what features of the input correspond to negative predictions,
and what features correspond to positive predictions.
The ANN, SVMs, and RF models had the best average classification accuracy (81.5%), but of this group,
there was not one classifier that performed significantly better than the others. These classifiers could be
used to help non-experts select clones from either library F or S for further wet-lab analyses.
The SVMs trained on library F and tested on library S achieved an average classification accuracy of
66.7%, significantly better than would be achieved by relying on chance. These two SVMs could be used to
help non-experts select clones for further wet-lab analyses, provided the library being used is not too different
from library S.
Finally, deconstructing the SVMs trained on library F yielded insight into the basis for their predictions.
The predictions of the RBF-SVM were found to be highly dependent on the molecular weight of the relevant
binding region (i.e. CDRH3).
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The general aim of this thesis was to apply methods from an area of artificial intelligence called machine
learning to a lab technology used for antibody discovery called antibody phage display. This introduction
provides (1) a brief background for understanding this aim, (2) the motivation for this aim, (3) the research
goals of this thesis, (4) an outline of the methodology of this thesis, and (5) an explanation of how this
document is organized.
To defend against microbes and prevent infection, the human body is equipped with multiple layers of
defence including the two main branches of the immune system: the innate immune system and the adaptive
immune system. The innate immune system, evolving much earlier in history, recognizes molecular hallmarks
of pathogenicity and responds to these hallmarks by sending cells and proteins to eliminate the hallmark-
bearing pathogen. Some pathogens, however, do not carry any hallmarks that the innate immune system can
recognize. To handle threats like these, vertebrates have evolved an adaptive immune system, which consists
of specialized cells and proteins that recognize molecules that are not part of the organism. Proteins called
antibodies play a pivotal role in this recognition mechanism.
Antibodies help the adaptive immune system distinguish self from non-self and focus resources toward
eliminating the latter. The body is capable of producing a variety of antibodies that recognize the vast
majority of non-self molecules. Even though each antibody only recognizes a specific molecular signature,
the variety of antibodies produced by the body is so immense (roughly 1012 [1]) that, for any given target,
it is very likely that there exists an antibody that can bind to that target. Antibody structure and function,
and clonal selection—the process the body uses to produce pathogen-fighting antibodies—is discussed in the
background of this thesis (Section 2.1).
The ability of organisms to produce antibodies that bind strongly and selectively to proteins has been
exploited to produce polyclonal antibodies (pAbs) for use in diagnostics (e.g. ELISA) and therapeutics. In
addition to pAbs, there is great interest in developing monoclonal antibodies (mAbs). MAbs differ from
pAbs in that all of the antibodies in a mAb originate from the same cell and are thus identical in sequence
and structure, whereas the the antibodies in a pAb originate from different cells and are thus heterogeneous.
MAbs are attractive because, among other reasons, they are easier to study and easier to reproduce [2].
Since the production of the first monoclonal antibodies in 1975 and the first FDA licence in 1986, mAbs
have become an important weapon in the clinician’s arsenal [3]. Today, there are approximately 30 mAbs
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approved by the FDA for treating human disease and conditions like cancer, chronic inflammatory diseases,
transplantation rejection, infectious disease, and cardiovascular diseases [3]. The importance of mAbs is
underscored by their global market value, which stands at approximately 20 billion USD per year; and the
success of mAbs like Ramicade and Rituxan, which have annual sales exceeding 1 billion USD [4].
There are a variety of methods for developing mAbs with an affinity towards a target of interest. One such
method is called antibody phage display. Antibody phage display uses bacterial viruses, called bacteriophage,
to achieve clonal selection of target-binding antibodies in the lab. The procedure begins with a library of
bacteriophage expressing antibody fragments on their capsid and carrying the corresponding gene in their
genetic payload. In a process called panning, phage displaying target-binding antibody fragments are enriched
by incubating the phage in a target-coated well, rinsing the unbound phage away, and then amplifying the
immobilized target-bound phage by infecting a bacterial culture. A more detailed explanation of antibody
phage display is given in Section 2.2.
One of the main goals of antibody phage display is to isolate phage that bind strongly, and specifically, to
the target of interest. For therapeutic applications, target affinity is critical for increasing efficacy, reducing
the required dosage, and easing side effects [5]. Because antibody phage display cannot generate antibody
fragments that do not already exist in the library, the diversity of the initial library is critical to the success
of the technique. Even if the library is sufficiently diverse and contains target-binding phage, antibody phage
display may still fail due to other phage out-competing the target-binding phage, essentially masking them
from discovery.
In order to understand library diversity and the enrichment process that happens during panning, studies
have incorporated next-generation sequencing (NGS) [6, 7, 8]. NGS allows researchers to identify every
sequence in a phage pool and approximate its concentration; however, to conduct an in-depth analysis on
this data, intelligent and efficient computational methods are needed. Making sense of large datasets is a
focus of machine learning. In addition, machine learning stresses computational efficiency and makes few
assumptions about the process that gave rise to the data. An overview of machine learning as well as some
of the specific techniques used in this thesis is given in Section 2.4.
This thesis will explore machine learning methods of leveraging NGS outputs from antibody phage display
experiments with a view toward the following goals: (1) comparing the effectiveness of various machine
learning techniques to this problem domain, (2) choosing the best machine learning method and validating
its performance, and (3) demonstrating how machine learning can be used to inform the design of antibody
libraries with enhanced specificity. These research goals are described further in Chapter 3.
To realize the goals of this thesis, NGS sequence outputs from real antibody phage display experiments
conducted by the Geyer lab were processed to make them suitable for input to machine learning methods. A
software package called Weka was used to train various machine learning methods for the task of predicting
whether or not a specific clone will be observed after 5 rounds of panning given the CDRH3 sequence of that
clone. Cross-validation was used to compare the performance of the machine learning methods and hone in
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on one of the best techniques, called Support Vector Machines, which is described in Section 2.4.5. The SVMs
were trained to predict outcomes of antibody phage display and then they were dissected to understand the
basis for their performance and to suggest ways of modifying the antibody phage display library to improve
specificity toward the targets used in the experiments. A complete description of the methodology is given
in Chapter 4.
Listed in order, this thesis includes the following chapters: Background, Research Goals, Methodology,
Results & Conclusions, and Discussion & Future Work. Background will overview theory, techniques, and
literature that are necessary to understand the rest of the text. Research Goals states the specific objectives
of this thesis. Methodology lays out the work that was done to complete the research goals, and provides
the necessary detail for reproducing the work. Results & Conclusions presents the observations and con-
clusions made during execution of the methodology. Discussion provides general commentary including the






To avoid infection the human body must fight off microbes like viruses, bacteria, and parasites and to mount
a defence against these pathogens, the body must have the capacity to distinguish them from self-molecules.
A big part of this recognition mechanism is the responsibility of proteins called antibodies.
Antibodies are symmetrical Y-shaped proteins capable of recognizing and binding specific molecular sur-
faces (called epitopes) with two of its three branches (called the variable regions). During the development
of antibody-producing cells, called B-cells, the antibody-coding genes of these cells are systematically ran-
domized so that each B-cell produces its own antibody variant that recognizes a unique molecular surface.
Because the number of antibody variants produced by this randomization process is so immense, the body
has the capacity to produce antibodies that recognize nearly any molecular surface. To eliminate antibodies
that are self-reactive and leave only those that react to foreign molecules, B-cells producing antibodies that
are self-reactive are culled out in a process called negative selection. The result is an antibody repertoire
that reacts to almost any threat but not to the body [9].
To accommodate such a large diversity of antibodies, the concentration of each antibody in the body
is minuscule. In response to an infection, the body uses a process called clonal selection to increase the
concentration of antibodies that bind to the invading pathogen. The process of clonal selection depends on
the cells that produce antibodies, called B-cells. In addition to producing free-floating antibodies, a B-cell
is decorated with membrane-bound proteins resembling antibodies, called B-cell receptors (BCRs). When a
suitable antigen binds to a BCR, the BCR sends a signal to the B-cell that causes it to proliferate. As the
B-cell proliferates, it also upregulates the production of antibodies. In this way, only antibodies that can
actually aid in the battle against the invading pathogen are actually produced [9].
2.1.2 Structure
A detailed view of an antibody molecule is shown in Figure 2.1. Conceptually, the structure of an antibody
has the shape of the letter Y. This Y is composed of four chains: two identical heavy chains (Hc) and two
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Figure 2.1: Structure of an antibody [10, 11]. Heavy chains are coloured red and light chains are
coloured yellow.
identical light chains (Lc). The C-terminal halves of both heavy chains associate to form the stem of the Y
while the N-terminal halves are divided between the two top branches, each associating with one of the light
chains (Figure 2.2a) [9].
The parts of an antibody can be classified based on their function within the molecule. In order of
increasing specificity, these regions are Fc, Fab, Fv (Figure 2.2b), and CDRs. The Fc region refers to the
stem of the Y and is also called the constant fragment because it is identical in every antibody. The Fc
region is also the part that is recognized and bound by other components of the immune system. The two
remaining branches of the Y-shaped antibody are called Fabs, or antibody binding fragments. Within each
Fab is the Fv region, also called the variable region. Finally, at the N-terminal tip of the Fv region resides
the CDRs (complementarity determining regions). The CDRs are six loops (three from the heavy chain
and three from the light chain) which are responsible for sticking to the molecular surface of the antigen
(termed the epitope). Three of these CDRs (CDRH1, CDRH2, and CDRH3) come from the heavy chain.
The other three (CDRL1, CDRL2, and CDRL3) come from the light chain. Antibody diversity is created
by randomizing the genes encoding these loops. The reader can learn more about antibodies in the text by
Sompayrac [9].
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(a) Antibody molecule coloured by chain. Heavy





(b) Antibody molecule coloured by region. The con-
stant region (Fc) is shown in green, the Fabs are
shown in red (light and dark), and the variable re-
gions (Fv) are shown in dark red.
Antigen
(c) An antibody bound to an antigen. The surface making contact with the antigen is formed by the 6 CDRs (not
shown) of the variable region. The surface of the antigen making contact with the antibody is called the epitope.
Figure 2.2: A diagram of an antibody molecule.
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2.2 Antibody Phage Display
2.2.1 Overview
The observation that (1) human antibodies are well-tolerated by the body, (2) antibodies are highly specific
to their target, and (3) an antibody can be made for any given target, has lead to a great investment in
using antibodies for research, diagnostics, and therapeutics [3]. Much of the interest in antibodies is focused
on monoclonal antibodies (mAbs). A mAb is a collection of antibodies that are identical copies, or clones,
of one another. To avoid confusion, in the remainder of this document, the term clone means “a collection
of identical antibodies”. This definition will replace the alternate meaning of the word, which is “a single
copy of an antibody”. For example, a mAbs consists of a single clone, whereas polyclonal antibodies (pAbs),
which are heterogeneous collections of antibodies, consist of multiple clones.
Antibody phage display is a lab technique used for developing mAbs with affinity toward targets of
interest. Whereas the proliferation of antigen-binding antibodies within the human body is an example of
in vivo clonal selection, antibody phage display is a method for in vitro clonal selection. Antibody phage
display exploits the biology of bacteriophage (viruses that infect bacteria) to achieve this selection.
2.2.2 In Vitro Selection via Panning
Antibody phage display begins with a library: a collection of phage-antibody hybrids displaying antibody
fragments on their surface. An antibody phage display library typically contain over 1010 different clones
[12], comparable to the diversity of the human antibody repertoire. One might then expect that, for a given
target, there exists an antibody in the library that can bind to that target. Such a hypothesis is tested
using a selection process called panning. Panning has three basic steps: incubate, wash, and amplify. When
conditions are ideal, these steps enrich target-binding phage. Panning can be repeated a number of times
to achieve further enrichment. In the incubation step the phage are pipetted into target-coated wells. With
time, phage that display antibodies with target-affinity become immobilized on the surface of the well. The
next step is to rinse the well several times to wash away any unbound phage. With separation of bound and
unbound phage achieved, the final step is to either recover the DNA of the phage or to amplify the bound
phage remaining in the well so that further enrichment steps can be completed. Amplification is achieved by
infecting a suitable bacterial culture.
Sequencing of the antibody fragments present in the phage results in thousands to millions of sequences
in which a number of highly redundant sequences can be found. Barring sequencing errors, each set of
redundant sequences come from a set of identical phage, called clones. The general idea is that the more
abundant a sequence, the more abundant the clone, and thus the higher affinity that clone has for the target.
Next-generation sequencing of antibody phage display samples is common [6, 7, 8]. The reader can find an
overview of phage display in the work of Carmen & Jermutus [14].
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Figure 2.3: A pool of Fab-phage are selected and amplified to enrich those that bind to the target
(also called the antigen). (1) A pool of Fab-phage are incubated in an antigen-coated well; (2) Unbound
Fab-phage are removed by washing the well with solution, leaving Fab-phage that bound the antigen;
and (3) the antigen-bound Fab-phage are eluted from the antigen and amplified in an E. coli host.
The process can be repeated to further enrich antigen-binding Fab-phage [13]
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2.2.3 Antibody Library
In antibody phage display, a population of phage is called a library. One common, albeit simplistic, metric
for the quality of a library is its diversity, or number of distinct clones. Some state-of-the-art libraries have
estimated diversities of over 1010 clones, rivalling the diversity of the human antibody repertoire [12].
Libraries are constructed with DNA coding for antibody fragments with diverse variable regions. Each
DNA fragment is then inserted into a vector coding for a bacteriophage capsid protein such that the expression
product of the vector is a fusion protein between the capsid and the antibody fragment. The recombined
vector is then transfected into a bacterial culture infected with the same type of bacteriophage. During
virion assembly, the fusion protein is incorporated into the phage capsid alongside the wild-type capsid
proteins, producing bacteriophage that display the antibody fragment on their surface. Moreover, the DNA
of the vector contains specific signals that allow it to be packaged within the phage progeny. The result is
bacteriophage carrying the DNA of the antibody that decorates their surfaces. The linkage between antibody
DNA and antibody fragment turns out to be crucial for in vitro selection [14].
The DNA used to construct antibody phage display libraries can be derived from the antibody repertoire
of an organism, or synthesized using a template antibody and a suitable mutagenesis technique. Constructing
an antibody library synthetically offers greater control over the makeup of the constructed library. The CDRs
of synthetic libraries can be made to follow a specific design. For example, the libraries studied in this thesis,
library F and library S, were constructed synthetically according to the specification shown in Table 2.1 [14].
Library F is a synthetic antibody phage display library that uses a constant antibody framework and
variable CDR-H1, H2, H3, and L3, with most diversity focused toward CDR-H3. The length of CDR-L3 and
H3 varies from 8 to 12 residues and 7 to 23 residues, respectively. Library S was designed around library F,
but unlike library F, contains no variability in CDR-H1 and H2, and has a CDR-H3 that can vary in length
from 7 to 25 residues. The specification for library F and library S is shown in Table 2.1 [13].
2.2.4 Panning Target
In antibody phage display, the molecule one wishes to develop an antibody for is called the target. Seven
protein targets used in experiments carried out by the Geyer Lab are shown in Table 2.2.
2.3 Computational Biology
2.3.1 Sequence Alignment
Biological sequences, such as DNA and proteins, are easily represented using strings of symbols (i.e. sequences
of characters). For example, the DNA sequence consisting of the bases guanine-adenine-thymine-thymine-
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Table 2.1: CDR specifications for library F and library S. One-letter abbreviations are used to signify
amino acids. Brackets signify that any of the contained amino acids may appear at the position in the













H3 S AR[YSGTAPHREFWVL]1-10[AGDY]FDY and
AR[YSGAFWHPV]7-15YYYY[GY][MF]DV
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Table 2.2: Summary of protein targets.
Short Name Full Name Gene Description [15]
Axl Tyrosine-protein kinase receptor AXL Cell signalling receptor that helps
regulate cell survival, cell prolif-
eration, migration, and differen-
tiation.
Jagged1 Protein jagged-1 JAG1 Ligand for Notch receptors. Be-
lieved to affect cell-fate decisions
during hematopoiesis.
Jagged2 Protein jagged-2 JAG2 Ligand for Notch receptors. Af-
fects limb, craniofacial, and
thymic development.
Mer Tyrosine-protein kinase Mer MERTK Cellular signal receptor that reg-
ulates cell survival, migration,
differentiation, and phagocytosis.
Notch1 Neurogenic locus notch homolog protein 1 NOTCH1 Receptor for jagged-1 and jagged-
2 (see JAG1/JAG2).
Notch2 Neurogenic locus notch homolog protein 2 NOTCH2 Receptor for jagged-1 and jagged-
2 (see JAG1/JAG2).
Notch3 Neurogenic locus notch homolog protein 3 NOTCH3 Receptor for jagged-1 and jagged-
2 (see JAG1/JAG2).
adenine-cytosine-adenine can be represented as the string “GATTACA”. This unambiguous representation
is easily manipulated by computers, which enables computers to carry out useful biological operations like
sequence alignment.
Sequence alignment is usually carried out to determine whether two sequences are similar enough to
assume they share some characteristic (e.g. evolutionary history, protein structure, function etc.). In silico,
determining how similar two sequences are is carried out by finding the alignment which maximizes an
objective function called the scoring function. The scoring function expresses, in formal terms, how good an
alignment is. The resulting alignment can itself be represented as two strings, one shown above the other
as in Figure 2.4a. Sequence alignment can be performed on more than two sequence. Such an alignment is
called a multiple sequence alignment (MSA). An example of an MSA is shown in Figure 2.4b.
2.3.2 Position-weight matrix
A position-weight matrix (PWM) is one way to represent a MSA. In a position-weight matrix, the rows
represent each of the 20 amino acids and the columns represent each position in the MSA. The value stored













Figure 2.4: (a) Two possible alignments of the DNA sequence ATTA with the DNA sequence GAT-
TACA. A priori, the first alignment is better because it does not contain internal gaps. (b) A multiple
sequence alignment of the DNA sequences GATTACA, ATTA, and GATACA.
Figure 2.5: An example of a sequence logo [16].
2.3.3 Sequence Logo
A sequence logo is a visualization of an MSA. An example is shown in Figure 2.5. A sequence logo shows
the positions of the MSA along a horizontal axis. Above each position, a number of pictures are stacked
vertically. Each picture in the stack depicts a single symbol, but the symbol is stretched or squashed to occupy
a specific amount of vertical space. The vertical space occupied by the picture signifies the probability in
bits (− log2 P ) of observing the depicted symbol at the corresponding position in the MSA.
2.4 Machine learning
2.4.1 Overview
In data analysis, one deals with sets of repeated measurements, e.g. species, petal length, and petal width
for each iris in a garden. In their entirety, these measurements form a dataset.
The measurements in a dataset are often dealt with mathematically as vectors, e.g. an iris of species
versicolor having a petal length of 1.4′′, and a petal width of 0.2′′ can be encoded as the 3-dimensional vector
(versicolor, 1.4′′, 0.2′′). If all of the measurements are numerical, the vector can be thought of as a point in
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N -dimensional space, where N is the number of measurements associated with the observation. Thought of
this way, the observation is called a datapoint.
Machine learning deals with the development and application of algorithms that extract meaningful
patterns from large datasets. Sometimes these patterns reveal hidden structure in the dataset. Looking
for these kinds of patterns is dealt with in the area of unsupervised machine learning. An example of
unsupervised machine learning is shown in Figure 2.6. Other times, these patterns are used to predict the
unknown attributes from partial observations, e.g. predicting the species of an iris from its petal length and
width. Looking for these kinds of patterns is dealt with in the area of supervised machine learning [17].
To predict unknown attributes, supervised machine learning techniques use a function or combination
of functions that takes a datapoint as input and outputs a number or label. This number or label output
by the model becomes the prediction for the unknown attribute. Before the model can make reasonable
predictions, however, it must first be trained with a dataset. Training allows the model to learn apparent
relationships between the known attributes, also called predictor variables, and the unknown attributes, also
called response variables.
Supervised machine learning can be further separated into classification and regression problems. A
regression problem arises when the response variable is continuous (in the mathematical sense). An example
of a regression problem is trying to predict the height of an individual based on a set of genetic predictors. A
classification problem arises when the response variable is categorical (i.e. can be enumerated). An example
of a classification problem would be trying to diagnose a patient as either infected or healthy based on a set
of clinical observations.
2.4.2 Training and learning
The functions that make up a machine learning model contain a number of adjustable parameters that affect
the predictions the model makes. A training algorithm is an optimization procedure that adjusts these
parameters in order to minimize the prediction error on the training dataset. For example, in a linear model
having the form y = mx + b, the slope m and y-intercept b are the parameters that are optimized during
linear regression, a sort of training algorithm.
2.4.3 Testing and validation
After training a machine learning model on the training dataset, it is necessary to test the model on another
dataset, called the testing dataset. The purpose of testing is to show that the model has not simply learned to
remember the training dataset, but has actually learned meaningful patterns that generalize to observations
outside of the training dataset.
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Figure 2.6: A hypothetical example of unsupervised machine learning. (a) The initial data consisting
of two measurements: sepal length and sepal width. The initial data was subjected to clustering, which
tries to divide the data into well-defined groups. (b) The same data coloured red or blue according to
the clusters identified by a clustering procedure.
2.4.4 Hyperparameters
In addition to normal parameters, which are optimized during training, machine learning models often have
parameters which can be set by the user. These parameters are called hyperparameters. Hyperparameters can
have a broader impact on the resulting model than normal model parameters. An important consideration
in machine learning is finding the hyperparameter values that work best for a particular problem.
2.4.5 Machine Learning Techniques
Correlation-Based Feature Selection
In machine learning, raw input is often processed into a smaller set of variables, called features, which are
then fed into the machine learning tool to predict the response variable. The processing of raw input into
features is called feature extraction.
For a given prediction task, there may be features that do not correlate well with the response variable.
These features are said to be noisy. There may also be features that correlate so well with each other that
their combined predictive power is worth no more than the predictive power of each feature alone. These
features are said to be redundant. Correlation-based features selection (CFS) is a procedure invented by
Mark A. Hall [18] that selects noisy and redundant features to discard.
The main contribution of CFS is a method for measuring the merit of a feature set. The method uses
an equation that measures the average correlation between each predictor and the response variable, but
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penalized for correlation between predictors. CFS can handle not only continuous variables but ordinal,
nominal, and binary variables as well.
The Weka interface to CFS provides a number of common search strategies for finding the features that
maximize the CFS equation. One of these search strategies—the one used in this thesis—is called best-first
search.
The best-first search implementation can start with either (1) the empty set of features or (2) the set of
all features. In this thesis, the empty set of features was used, so only this method will be described but
before best-first search is described, some basic terms and concepts need to be defined:
Child: A feature set A is said to be the child of another feature set B if A contains all of the features of B
plus one more.
Expansion: The expansion of a feature set is the enumeration of all its children.
Best-first starts by expanding the empty set (e.g. Figure 2.7a). Expansion of the empty set results in the
discovery of a number of features sets, each containing only a single feature. The search continues by choosing
the best unexpanded set to expand next (e.g. Figure 2.7b). The search stops when 5 consecutive expansions
do not improve upon the CFS score of the best set. When the stopping criteria is met, the algorithm returns
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Figure 2.7: (a) The empty feature set is expanded, resulting in the discovery of three new feature
sets. (b) The feature set with the best CFS score ({b}) is expanded, resulting in the discovery of two
more feature sets.
Decision Trees and Random Forests
A decision tree is a classifier that uses a structured set of rules for classifying new instances (Figure 2.8). To
classify a datapoint using a decision tree, the rule at the root of the tree is applied first. If the rule is satisfied,
the next rule applied is the left descendent of the root, otherwise it is the right descendent. This proceeds
down the tree until a leaf node is reached. The label contained in the leaf node becomes the predicted class
of the datapoint.
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A decision tree can be built to correctly classify every datapoint in a dataset; however, the ability of such
a tree to generalize to other data is typically poor. A random forest is an attempt to counteract the poor
generality of a decision tree. A random forest is a collection of decision trees, each trained on a different
subset of the training data [19]. After training, the random forest contains a collection of decision trees that
are d ifferent, yet are trained to do the same thing. By averaging over the predictions of each decision tree,
a classifier that is less prone to overfitting results (i.e. less dependent on the training data).
For random forests, bagging and random feature selection are two methods for injecting randomness into
the training of each decision tree. In bagging, the training dataset is resampled before training each decision






















Figure 2.8: A hypothetical decision tree for deciding whether a pair of proteins interact [21].
Logistic Model
A logistic model is a prediction tool used for binary classification problems. The two classes of a binary
classification problem will be called the positive and negative classes. The input to a logistic model is a set
of numeric variables and the output is a number between 0 and 1 that approximates the probability that
the input belongs to the positive class. For a given input, if the logistic model produces a value of 0.5 or
greater, the model predicts that the input belongs to the positive class; otherwise, the model predicts that
the datapoint belongs to the negative class. A logistic model is trained by maximizing the likelihood function
of the model. The likelihood function expresses the probability that the model generates the observed data,











Figure 2.9: An example of a maximum-margin separating plane. (a) Datapoints with two variables
represented on the x and y axes. The red dots belong to one class and the blue dots belong to another.
(b) The maximum-margin separating plane shown as a solid black line. Datapoints labelled v1, v2,
and v3 are the support vectors of this plane. The margin is the space between the two dotted black
lines.
Support Vector Machine
A support vector machine (SVM) is a popular machine learning model used for binary classification problems.
SVMs can be understood by first visualizing data as coloured points in k-dimensional space, where the colour
denotes the class of the data point and the value on each of the k axes is the value of each of the k predictor
variables (Figure 2.9a). The goal in training an SVM is to find the maximum-margin separating plane, which
is the plane that separates points of different colours such that there is a maximum amount of space between
the plane and the points (Figure 2.9b). Visually, if the plane has a thickness, the goal is to find the thickest
plane that separates the points. Once the maximum-margin separating plane is found, predictions for new
datapoints depend on what side of the plane the new datapoint falls. The reader can learn more about SVMs
in the text by Alpaydin [17].
Support vector machines get their name from the fact that the maximum-margin separating plane can
be defined in terms of a subset of the datapoints in the training dataset, called the support vectors. The
decision to classify a new data point as belonging to either the positive or negative class is made based on
the result of a linear combination of the inner-products between the new data point and each of the support
vectors. For example, in Figure 2.9b, the datapoints labelled v1, v2, and v3 are the support vectors of the
maximum-margin separating plane; the maximum-margin separating plane is defined completely by these 3
datapoints.
17
In addition to linear separating planes, support vector machines can classify using non-linear surfaces
by mapping the training data into another space with a special function and then performing the training
procedure in this new space. This mapping can be achieved implicitly by substituting the inner-product in
the decision function with another function. These functions are called kernels.
For real classification problems, separating all of the datapoints into their respective classes with a plane
may be impossible. For this reason, most SVMs use a soft-margin, which allows some of the training data
to be misclassified. The parameter C is introduced to control the balance between (1) the goal of making
the margin as large as possible, and (2) the soft-constraint that all training data be on the correct side of
the plane and outside of the margin [22]. Lowering the value of C softens the constraint, but the value of C
must remain positive.
Radial Basis Function
One example of an SVM kernel is a radial basis function (RBF). A RBF is shown in Equation 2.1, where γ
is an adjustable parameter and x and x′ are two vectors. Intuitively, the RBF kernel is a similarity function
that maps pairs of vectors into the interval [0, 1]. The RBF kernel is at a maximum (equal to 1) when the
pair of vectors are equal. As the distance between the vectors increases, the RBF kernel decays to 0. γ
controls how fast a RBF decays and must be positive.
K(x,x′) = exp(−γ||x− x′||) (2.1)
When fed a vector as input, a RBF-SVM classifies the vector through the following procedure: For each
support vector, the RBF-SVM calculates the distance to the input vector, multiplies this distance by −γ,
then takes the exponential of the result. The resulting term is multiplied by the weight of the support vector.
Finally, the RBF-SVM sums the resulting terms and adds a constant term, which was also learned during
training. If the sum is positive, the RBF-SVM classifies the input as positive; otherwise, it classifies the input
as negative.
Strings, Subsequences, and the String Subsequence Kernel
A string is a sequence of symbols from a predefined alphabet. For example, a DNA sequence is a string that
is made from the symbols A, T, G, and C. A substring of a string s is a string that can be made into s by
adding symbols to either end. A subsequence of a string s is a string that can be made into s by adding
symbols anywhere in the string. For example, consider the string s = GATTACA. ATTA is a substring of s
but ATTC is not; however, ATTC is a subsequence of s.
In the context of molecular biology, DNA or amino acid sequences can be represented by strings. A
substring of a string s can therefore be thought of as an ungapped local alignment on s that does not contain













Figure 2.10: Substrings and subsequences in a molecular biology context. (a) A substring s′ of s is
an ungapped local alignment of s′ onto s that contains no mismatches. (b) A subsequence s′′ of s is a
local alignment of s′′ onto s that contains no mismatches and only contains gaps in the s′′ part of the
alignment.
mismatches and only contains gaps in the subsequence part of the alignment. Examples of a substring and
subsequence in this context are shown in Figure 2.10.
The string subsequence kernel (SSK) is a more exotic SVM kernel because it operates on strings instead
of vectors [23]. Intuitively, the SSK is the number of subsequences shared between two strings and weighted
by the number of gaps in the shared subsequences. The SSK kernel is parameterized by two parameters, the
decay λ and the subsequence length n. Intuitively, the decay λ determines how much shared subsequences
are penalized for containing gaps.
Artificial Neural Network
An artificial neural network (ANN) is a machine learning tool composed of nodes and edges. An example of
a small ANN is shown in Figure 2.11. The nodes in an ANN are processing units which sum together signals
from adjacent nodes, apply a function, and send the resulting signal to nodes further down the network
through its outgoing edges. The edges in an ANN not only connect node outputs to node inputs, but also
multiply the signals they carry by a weight.
In feedforward ANNs (the kind of ANN used in this thesis) nodes are organized into layers, where the
first layer contains nodes that receive the input, and the final layer contains nodes that produce the output.
The layers in between the input layer and output layer are called hidden layers. Every node in layer i is
connected to every node in layer i+ 1. In addition, each layer has a bias node capable of shifting the entire
signal up or down. Figure 2.11 shows an example of a feedforward ANN.
The goal of training an ANN is to find values for the edge weights that minimize the prediction error
of the ANN with respect to the training dataset. This minimization problem has no direct mathematical
solution, but a numerical procedure called gradient descent can find values that are locally optimal.
Gradient descent requires initial values for the edge weights. The initial values may be supplied by the user
and drastically affect the outcome. Using the initial values, the direction of steepest descent is determined by
taking the derivative of the training error with respect to each edge weight. Each edge weight is then adjusted
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0,0 0,1 0,2 0,3
1,0 1,1 1,2 1,3 1,4
2,1
Figure 2.11: An example of a small artificial neural network. Nodes are labelled x, y where x and
y denote the layer and node, respectively. By convention, layer 0 is the input layer and node 0 is the
constant bias. The nodes in the input layer (shown in blue) take on the values of the predictor variables.
The signal propagates down the edges to adjacent nodes. At each edge the signal is multiplied by a
weight. At each node the signals are added together, transformed with the activation function, and
sent through the outgoing edges. Eventually the signal reaches the output node (shown in red) which
predicts the value of the response variable.
to move in this direction by a certain amount. The size of this step is determined by the learning rate. The
gradient descent process is often compared to the trajectory of a ball that has been placed randomly on a
curved surface. The ball has a random initial position (the initial edge weights) and the elevation of the
ball (the training error) is determined by the surface (the training error). The ball moves in the direction of
steepest descent, eventually stopping at the bottom of the basin. By analogy, the edge weights move in the
direction of steepest descent (with respect to the training error) and stop when the edge weights reach values
where any movement, no matter the direction, increases training error. Optionally, a momentum may also
be introduced to allow the ball to roll against the direction of descent and jump from one basin to another.
The reader can learn more about ANNs in the text by Bishop [24].
Naive Bayes Network
A naive Bayes network is a simple machine learning model in which every predictor variable X is assumed to
be conditionally dependent on the response variable Y but independent of all the other predictor variables.
Naive Bayes networks are trained by estimating the conditional probability (P (X|Y )) for each predictor
variable using maximum likelihood estimation [19]. A trained naive Bayes network is used for prediction by
applying Bayes’ rule (Equation 2.2). The graph of a naive Bayes network is shown in Figure 2.12.




YX1 X2 · · · Xn
Figure 2.12: A naive Bayes network. Nodes denote variables and arrows denote conditional depen-
dencies between variables.
2.4.6 Related Machine Learning Applications
Machine learning has many fruitful applications in the field of molecular biology. One example is the detection
of CpG islands with hidden Markov models [25]. Another example is the prediction of protein secondary
structure from protein sequence using artificial neural networks [26]. A third example is the prediction of
interacting protein pairs using random forests [27]. Machine learning has also been used in drug development
for screening millions of drug candidates for those that are likely to fail [28].
2.5 Statistical Methods
Statistical tests allow one to support or refute hypotheses by deferring to statistical probabilities.
2.5.1 Wilcoxon Signed-Rank Test
The Wilcoxon signed-rank test is a non-parametric (i.e. distribution-free) test that can be used to compare
the medians of two related samples. The samples must be related in the sense that there is a natural way to
pair the data. An example of two such samples arises when a medical intervention is being tested on a patient
group and measurements are taken before and after the intervention. In this example, the pre-intervention
measurements form one sample, and the post-intervention measurements form the other. In addition, the
measurements in both samples can be paired according to the patient they came from. Pairing the samples
has the advantage of controlling for variables that differ between patients.
Using the example of the previous paragraph, the Wilcoxon signed-rank test helps answer the question
“are the measurements taken after the intervention consistently higher (or lower) than the measurements
taken before the intervention?” [29].
2.5.2 Friedman Test
If the data can be tabulated like the example shown in Table 2.3, the Friedman test can be used to test
the hypothesis that the observations in one or more of the rows are statistically higher (or lower) than the
other rows, while controlling for variables that differ between columns. The Friedman test is similar to the
Wilcoxon signed-rank test except that the Friedman test is not limited to pairs of datapoints. The drawbacks
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Table 2.3: The grades receieved by 3 students in the subjects math, science, and english. The
Friedman test could be used to test the hypothesis that one or more students received statistically
higher (or lower) marks than the others.
Student Math Science English
A 65 50 95
B 60 70 90
C 80 85 60
of the Friedman are that (1) it is less sensitive than the Wilcoxon signed-rank sum test (i.e. more likely to
falsely accept the null hypothesis) and (2) it does not indicate which row is dominant [29].
2.5.3 Mann-Whitney U test
Like the Wilcoxon signed-rank test, the Mann-Whitney U test can be used for comparing two samples, except
that the samples do not need to be paired [29].
2.5.4 Multiple Hypothesis Testing and the Bonferroni Correction
If, instead of a single hypothesis, a group of hypotheses are being tested using a dataset, the probability of
falsely rejecting a null hypothesis increases in proportion to the number of hypotheses. Using the example
from Section 2.5.1, such a situation might arise if, instead of testing one intervention, multiple interventions
are being tested.
One way to account for the increased chance of error associated with multiple hypotheses is to use the
Bonferroni correction [29]. The Bonferroni correction ensures that the change of falsely rejecting a single null
hypothesis is less than the significance level α.
2.6 Software
2.6.1 MUSI
Clustering is one example of unsupervised machine learning. The goal of clustering is to find groups (i.e.
clusters) of datapoints that are similar to each other but different from datapoints in other groups. An
example application of clustering is classifying patients diagnosed with a particular disease into disease sub-
types based on clinical observations and disease outcomes.
MUSI (Multiple Specificity Identifier) [30] is a software package that performs clustering on a set of short
peptide sequences. The MUSI algorithm first performs a mulitple sequence alignment (Section 2.3.1) on
the peptide sequences before selecting a set of PWMs (Section 2.3.2) to represent the MSA. The selection
procedure returns the maximum number of PWMs (fit using expectation maximization) that satisfy the
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MUSI criteria: (1) each PWM (i.e. cluster) has enough sequences and (2) no two PWMs are too similar.




Next-generation sequencing has enabled scientists to examine the DNA of biological systems (e.g. hu-
mans, eukaryotes, bacteria, viruses, and environments) with unprecedented detail. With the high volume of
information produced by NGS, however, comes the oft-cited challenge of storing, organizing, processing, and
analyzing this sequence data. Comprehending such high volumes of data is impossible to do manually. Not
excluded from these difficulties is the area of antibody phage display, where phage populations containing
millions of genetically distinct clones can be characterized in a single NGS run, allowing researchers equipped
with the right tools to perform an in-depth analysis of the sequence landscape present within the population.
The deluge of sequence data produced by applying NGS to antibody phage display presents a unique
challenge to the computational biologist. Each sequenced sample provides a detailed snapshot of the make-
up of the contained phage; but the factors that account for changes in the population observed between
snapshots is understood primarily on a qualitative level. While this high-level understanding coupled with
the researcher’s own experience has been sufficient to bring about major advances in the field [31], there is
still opportunity to bring to bear machine learning techniques to this exciting new area.
The aim of this thesis is to explore applications of machine learning to antibody phage display in the
following context: Given the sequence of a clone and a target, can the presence or absence of a clone after
the 5th panning round be predicted? As the presence or absence of a clone in the third, fourth, and fifth
rounds of panning is one of the first criteria the analyst uses in selecting clones for further experimentation,
this prediction task is a good candidate for machine learning.
The aim of this thesis was distilled into three research goals, which are presented in the following three
sections (Sections 3.1 to 3.3).
3.1 Compare the Performance of Various Machine Learning Tech-
niques in Application Area
The field of machine learning is rife with techniques for learning complex patterns from data and making
predictions based on those learned patterns [17, 24, 19]. No single technique is strictly dominant, but
each has areas of application where it excels. The first research goal of this thesis is to develop a general
methodology for applying different machine learning models to the prediction task at hand, and then to
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use this methodology to compare the classification accuracy of a variety of machine learning models. The
general methodology must prescribe methods for (1) identifying and extracting informative features from the
CDRH3 sequence data and (2) tuning the hyperparameters of the models.
3.2 Assess the Generality of the Prediction Pipeline
The usefulness of a trained machine learning model depends crucially on its ability to generalize to data not
observed in the original training set, a concept called generality. The second research goal is to determine to
what extent the best machine learning technique (chosen based on the results from the previous research goal)
can generalize to antibody phage display experiments that use different libraries. Such a finding would suggest
that the selected machine learning technique can find relationships between a clone’s CDRH3 sequence and
its outcome that are independent of the library.
3.3 Present a Methodology for Interpreting the Trained Models
Decisions for library construction are made on the basis of experience, intended targets, and resources.
Libraries may go through an iterative process of improvement by altering the original specification or con-
struction protocols. Machine learning models vary in their explanatory power; that is, the ease at which their
predictions can be understood in terms of the material inputs. By reverse engineering the learned classifier
in the prediction pipeline, general properties can be derived which correlate with the experiment outcomes
and the fate of clones. These properties can be interpreted as a prescription for further specialization of
the antibody library into a focused antibody library. The third goal of this thesis is to develop one possible




4.1 Work Performed by the Geyer Lab
Using antibody phage display, the Geyer Lab [13] selected clones from library F and library S for affinity to
seven targets named Axl, Jagged1, Jagged2, Mer, Notch1, Notch2, and Notch3 (Table 2.2). Screening was
carried out in a series of 14 antibody phage display experiments, each experiment using a different library-
target combination. To achieve sufficient enrichment of target-binding clones, 5 rounds of panning were used
in each experiment. After each round of panning, samples of the resulting phage population were sequenced
using an Ion Torrent sequencer.
For sequencing, the Geyer Lab [13] amplified the CDRH3 region of selection outputs (phage samples)
using designed primers; then performed emulsion PCR on the amplicons using proprietary Ion sphere particles
(ISPs); and finally sequenced the enriched ISPs on an Ion semiconductor chip. The sequences output by Ion
Torrent were prepared for data analysis with a sequence of steps that included the removal of reads that
diverged significantly from the library specification and reads with a low overall quality.
Because the sequenced samples form the basis of the following analysis, an unambiguous terminology
for referring to different collections of them was devised. Samples can be identified uniquely by the library,
target, and panning round from which they were collected; therefore, they can be said to form a 3-dimensional
array with library, target, and panning round represented on the 3 axes. Figure 4.1 shows this 3-dimensional
representation. Using this analogy, when an analysis is described as being performed on the S-Notch3 sample
array, samples from S-Notch3 rounds 0-5 are implied (Figure 4.1b).
For a typical sample, thousands of sequences were identified, many of which were identical. It was
assumed that identical sequences came from identical clones and that the number of identical sequences was
proportional to the concentation of that clone.
4.2 Data Organization
The CDRH3 DNA sequences produced by the Geyer Lab were translated into amino acid sequences using
the transeq program from the EMBOSS package [32]. The resulting protein sequences were inserted into a












































































(b) Library S-Notch3 sample array.
Figure 4.1: The phage samples viewed as a 3-dimensional array of cubes. (a) The sample collected
following round 5 of panning Library S against Notch3, denoted S-Notch3-5. (b) The samples collected
in all Library S versus Notch3 panning rounds, denoted S-Notch3.
target, and round columns; and then counted. These unique entries were inserted, along with their counts,
into a table called clones.
The reason for managing data with a DBMS like PostgreSQL was two-fold: (1) PostgreSQL ensures that
the entered data is valid and (2) querying a flatfile requires that, at worst, the entire file first be read, a
time-consuming operation, whereas PostgreSQL stores data in a native binary format which is designed for
rapid retrieval of information.
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4.3 Feature Extraction
The sequences in the clones table were preprocessed to extract a diverse collection of potentially informa-
tive features. These features can be divided into 3 groups. The first of these groups contains the amino
acid compositions of the 20 amino acids (Section 4.3.1). The second contains the counts of each dipeptide
(Section 4.3.2). The third contains a variety of physicochemical properties (Section 4.3.3). After extracting
these features, a preliminary analysis was conducted to gain a better understanding of the data.
4.3.1 Amino acid composition
The amino acid composition of a clone was the fraction of the clone’s variable CDRH3 sequence made up by
each of the 20 possible amino acids. An example calculation is shown in Table 4.1.
Table 4.1: Calculating the amino acid composition for the sequence YYYYVYDFDY.






The dipeptide counts for a clone were the number of each of the 384 different dipeptides present in the clonal
variable CDRH3 sequence. Out of the 400 possible dipeptides, 16 were omitted from this set of features
because they were not observed in any of the sequenced samples. A sequence of length l contained l − 1
dipeptides, so the sum of the dipeptide counts for a clone with a sequence of length l was equal to l − 1.
Calculating the dipeptide counts for the sequence YYYYVYDFDY is shown in Table 4.2.
The motivation for using dipeptide counts instead of fractions was based on an analogy with binding
motifs in protein sequences. Let X be a well-known binding motif for target T and let A and B be two
proteins that have X in their sequence. Also, assume that the number of amino acids in protein B is half the
number in protein A. In this hypothetical scenario, knowing how many times X occurs in A or B is more
relevant than whether these proteins bind to T than knowing the fraction of A or B made up by X because
the answer does not depend on the size of the protein. Following the analogy, if a dipeptide is viewed as
a micro-motif of the CDRH3, which can vary is size, then the question of how many times that dipeptide
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occurs in the CDRH3 is more informative than the question of what fraction of the sequence is made up by
that dipeptide.




















(b) Counting the dipeptides.
4.3.3 Physicochemical Properties
In addition, a collection of physicochemical properties were estimated for each clone’s sequence. These
features included the following eight physicochemical properties, calculated using the R package Peptides
(version 1.1.1) [34].
Aliphatic index: From Ikai [35]: “The relative volume of a protein occupied by aliphatic side chains (ala-
nine, valine, isoleucine, and leucine).”
Boman index: The average solubility value of the amino acids in the sequence.
Charge: The net charge of the sequence.
Hydrophobicity: The average hydrophobicity index of the amino acids in the sequence.
Instability Index: An index of how rapidly a protein will degrade. A protein that has an index less than
40 is considered stable (e.g. has a very long half life) [36].
Length: The number of amino acids in the sequence.
Molecular weight: The combined molecular weight of the amino acid sequence.
Isoelectric point: The pH at which the protein has a net charge of 0.
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4.4 Comparison of Machine Learning Techniques
4.4.1 Overview
Each clone that was observed after 5 rounds of panning received a label of persistent and each clone that
was observed in the naive library, but not after round 5 received the label transient. A panel of classifiers
was trained to classify clones as either persistent or transient based on the clonal sequence. The panel of
classifiers consisted of a logistic model (LM), random forest (RF), support vector machine (SVM), artificial
neural network (ANN), and naive Bayes network (BN). Although by no means exhaustive, this list of classifiers
covers many of the popular machine learning classifiers used today. Using Weka [37], each classifier in the
panel was trained and tested on the features calculated for each library-target sample array. Because there
were 2 libraries, 7 targets, and 5 different classifiers, the analysis consisted of 70 subanalyses (2× 7× 5).
4.4.2 Dataset Preparation
For each experiment, the unique clones observed in round 5 were labelled positive. The positive dataset was
then subtracted from the unique clones identified in the naive library (round 0) to form the negative dataset.
Because the number of negative clones was much greater than the number of positive clones, the negative
dataset was randomly down-sampled until the size of the two datasets matched.
4.4.3 Feature Selection
Generally, the number of classifier parameters increases with the dimensionality of the feature space. A
large number of classifier parameters is associated with (1) longer training times, (2) overfitting, and (3) less
interpretable models. Because of these issues, dimensionality reduction is highly desirable.
A total of 413 features were extracted from each clone. These features were made up of 8 physicochemical
properties, 20 amino acid compositions, and 384 dipeptide counts. Uninformative features were removed
from the data to reduce the dimensionality of the feature space without compromising the ensuing analysis.
Two components were needed to find a subset of features (i.e. remove uninformative features): (1) a
criterion for evaluating the informativeness of a subset of features, and (2) a search algorithm. The criterion
was correlation-based feature selection (CFS) [18] and was described further in Section 2.4.5. CFS penalizes
noisy and redundant features when evaluating informativeness. An exhaustive search of feature subsets to
find the subset with the maximum CFS criterion was prohibitive because of the large size of the space of
feature subsets (2#-of-features). For computationally tractability, a best-first search was used with a stopping
point of 5 consecutive non-improving nodes.
The search algorithm was initialized with the empty set of features and proceeded through the feature
subset space by adding one feature at a time. The feature subset search was run on a dataset consisting of
250 positive clones and 250 negative clones from each library-target sample array.
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4.4.4 Training and Validation
Each classifier was trained and tested using 10-fold cross-validation on the feature-reduced datasets. The
following parameters were used for each classifier and training algorithm used to train that classifier.
Logistic Model: Default parameters were used.
Bayesian Network: Default parameters were used.
Random Forest: The random forest consisted of 100 decision trees. Each decision tree was trained using
the entire training dataset. Randomness was injected into the training procedure by randomly selecting
log2(num-of-features + 1) features from the feature-reduced dataset prior to training each decision tree.
This was the default heuristic used by Weka.
Support Vector Machine (RBF kernel): The support vector machine was equipped with an RBF kernel.
The cost C was set to 1 and γ was set to 0.01. Different parameter settings were investigated in the
analysis described in Section 4.6.2.
Artificial Neural Network: The number of hidden layers in the artificial neural network was set to 1. The
number of nodes per hidden layer was set to num-of-features+22 , the default heuristic used by Weka. The
learning rate and momentum (described in Section 2.4.5) were left at their default values of 0.3 and
0.2, respectively. Weka normalizes (centers and scales to unit variance) features by default prior to
training. This was not changed. Different numbers of hidden layers were also investigated as described
in Section 4.5.
4.4.5 Quantifying Prediction Performance
The classification accuracy was used for comparing the performance of the classifiers studied in this thesis.




4.5 Improving ANN Classification Accuracy
In an attempt to improve the classification performance of the ANN, different numbers of hidden layers were
tried. ANNs with 1, 2, and 3 hidden layers were trained and tested. Figure 4.2 shows the three ANNs that
were used.
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0,0 0,1 0,2 · · · · · · 0,n
1,0 1,1 1,2 · · · 1,m
2,1
0,0 0,1 0,2 · · · · · · 0,n
1,0 1,1 1,2 · · · 1,m
2,0 2,1 2,2 · · · 2,m
3,1
0,0 0,1 0,2 · · · · · · 0,n
1,0 1,1 1,2 · · · 1,m
2,0 2,1 2,2 · · · 2,m
3,0 3,1 3,2 · · · 3,m
4,1
Figure 4.2: Artificial neural networks with 1, 2, and 3 hidden layers. The input layer is coloured red
and the output layer is coloured blue. n is the number of inputs to the ANN and m is the number of
nodes per hidden layer. By default, Weka sets m to n+22 .
4.6 Improving SVM Classification Accuracy
Two methods of improving SVM prediction accuracy were explored. The first was the introduction of a new
type of kernel, called the String Subsequence Kernel (SSK). Whereas the RBF kernel, which was used in the
original comparison, operates on numerical vectors, the SSK kernel operates on strings allowing the clonal
sequence to be used as input. The second method of improving the SVM prediction accuracy was a gridsearch
to determine optimal parameter settings. The gridsearch was performed on both the origin RBF-SVM and
the newly introduced SSK-SVM.
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4.6.1 String Subsequence Kernel
The input to an SVM equipped with an RBF kernel is vectors in Rn, where n is the number of numerical
features describing each data point. The raw data used in this thesis consists of variable length sequences
and it was only by extracting various numerical features from these sequences that the sequences could be
projected into Rn so that the RBF-SVM could be used. To avoid having to choose a mapping of CDRH3
sequences to a vector space, which may not be information preserving, a kernel which operates directly on
sequences was used. This kernel is called the string subsequence kernel (SSK).
4.6.2 Gridsearch
Gridsearch was used to tune the parameters of the RBF- and SSK-SVMs. Because the computation time
of gridsearch scales exponentially with the dimensionality of the grid (i.e. the number of hyperparameters),
gridsearch was performed on just two hyperparameters at a time. For the RBF-SVM, the gridsearch was
performed on the parameter space formed by C and γ of the RBF-SVM and covering C = 10x for x =
−5,−4, . . . , 4, 5 and γ = 10x for x = −5,−4, ..., 4, 5. At each vertex of the grid and for each target, the
classification accuracy was measured using 10-fold cross-validation. For the SSK-SVM, the gridsearch was
performed on the parameter space formed by λ and n. The search covered λ = 0.1, 0.2, . . . , 0.9 and n =
1, 2, . . . , 6. At each vertex of the grid and for each target, the classification accuracy was obtained using
10-fold cross-validation.
4.6.3 Comparing the Tuned SVMs to the Original Classifiers
For both the optimized SVMs and the classifiers tested in Section 4.4, the cross-validation accuracies of each
classifier-dataset combination were averaged to obtain a mean accuracy. The mean accuracy of each SVM
was then compared to the mean accuracy of the original classifiers.
4.7 Cross-Library Validation of SVMs
In a separate analysis, the tuned RBF- and SSK-SVM were trained to predict clone persistence in one library
and then tested on the data from another library to see if the model generalized to a different experimental
setting. The library chosen to train the SVMs was library F because experiments by the Geyer lab showed
that library F worked well on all of the targets. Data from library S was used to test the SVMs. For
each target, an SSK-SVM was trained on the Library F sample array for that target and then tested on the
corresponding sample array in Library S. Classification accuracy was measured using 10-fold cross-validation.
The same analysis was conducted for the RBF-SVM.
The reasons for choosing the RBF- and SSK-SVM for this analysis and subsequent analyses are manifold:
(1) the RBF- and SSK-SVM were among the best performing classifiers in the analyses that was described
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in Section 4.4 (results are presented in Section 5.2.5); (2) compared to the ANN, the SVMs had a smaller
number of hyperparameters to tune; and (3) compared to RF, the SVMs were easier to interpret; and (4)
the SVM training procedure is guaranteed to find the best parameter settings. In addition, the SSK-SVM
works with sequence inputs. Using the CDRH3 sequence as input to the SSK-SVM avoided the problem of
choosing an intermediate vector representation of the CDRH3 sequence.
4.8 Interpreting the Trained SVMs
The SVMs that were trained on library F were inspected to understand the basis for their predictions. As
explained in the background (Section 2.4.5), SVMs make decisions based on a learned subset of training
examples called support vectors and a learned set of weights. These support vectors together with their
weights will be used to interpret the RBF- and SSK-SVMs.
4.8.1 Interpreting the Trained RBF-SVM
As described in Section 2.4.5, the decision function is a linear combination of the kernel between the input
and each support vector; therefore, the function resembles Equation 4.2, where K(·, ·) is a RBF, x is the
input, w1, w2, . . . , wn are the learned weights and v1,v2, . . . ,vn are the learned support vectors.
f(x) = b+ w1K(x,v1) + w2K(x,v2) + · · ·+ wnK(x,vn) (4.2)
As described in Section 2.4.5, the RBF is a similarity function that decays exponentially from 1 to 0 as
the Euclidean distance between the vectors increases; thus, each RBF in the decision function 4.2 creates
a peak or valley (depending on the magnitude of the wi). The decision function, when visualized in two
dimensions with a heatmap, contains “hotspots” at the positive-weighted support vectors and “coldspots”
at the negative-weighted support vectors. To visualize the decision function of the trained RBF-SVMs, the
decision function was projected onto two dimensions and plotted as a heatmap.
4.8.2 Interpreting the Trained SSK-SVM
As described in Section 2.4.5 the SSK maps a string s to a space of dimension |Σn|, where each dimension
is the weighted sum of occurrences of a particular word w ∈ Σn as a subsequence in s. The result of the
gridsearch over the parameter space of the SSK-SVM (to be described in Section 5.2.4) revealed that a
substring length of 2 (i.e. n = 2) was optimal, therefore the SSK used in subsequent analyses mapped strings
to a space of dimension 400 (i.e. one dimension per dipeptide). For example, the value of dimension AR for
sequence s was the number of times the dipeptide AR occurred as a subsequence in s. The decision function
of an SVM can be understood in terms of its support vectors, so the support vectors for the SSK-SVM
were decomposed into their underlying 400-component vectors consisting of dipeptide occurences. A positive
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weight on a dipeptide indicated that the presence of that dipeptide (as a subsequence) in a sequence made
it more likely to be predicted as a positive by the SSK-SVM. A negative weight meant the opposite.
4.9 Statistical Methods
In this thesis, non-parametric tests were generally preferred to parametric tests because of certain assumptions
required for the latter. One of the assumptions required for parametric tests is that the observations follow a
probability distribution (e.g. Gaussian distribution). As will be seen in future sections, no such assumption
can be made. The type of non-parametric tests used in this thesis were (1) the Mann-Whitney U test, (2) the
Wilcoxon signed-rank test, and (3) the Friedman test. The Bonferroni correction was used wherever multiple
hypotheses are tested. Unless indicated otherwise, hypothesis tests used a signficance level of 0.05 (i.e. if the
p < 0.05, the null hypothesis was rejected).
Whenever a test is used to support an observation like “the median of A is greater than B”, the null
hypothesis is the opposite; that the median of A is equal to or less than B. This is called a one-tailed test.
And whenever a test is used to support an observation like “the medians of A and B are not equal”, the null
hypothesis is, again, the opposite; that the medians of A and B are equal. This is called a two-tailed test.
The results of statistical tests are given in parenthesis, as close as possible to where they are mentioned.
Sometimes only a p-value is given (e.g. p = 0.05) and sometimes a confidence interval is given (e.g. M=1.0
CI=[-1.0,3.0]). When the statistic is a confidence interval, the median is denoted by the variable M , and the
95% confidence interval is denoted by the variable CI.
4.10 Hardware and Software
The classifier cross-validation jobs were run on the University of Saskatchdwan Bioinformatics Eldorado
server (hostname eldorado.usask.ca, 2 × 8-core Intel Xeon 2.60GHz, 384GB memory) taking advantage of
multiple cores where possible. Visualizations were generated on a laptop running Mac OS X.
Data manipulation was carried out at the database level with PostgreSQL and externally using Python
with pandas and Biopython [38]. The Weka machine learning workbench provided the routines for feature






The sequenced samples from the 14 experiments were submitted to a preliminary analysis in order to gain
a better understanding of the data. The preliminary analysis had three parts: (1) sequence clustering, (2)
calculating the diversity over panning round, and (3) computing the physicochemical property distribution.
5.1.1 MUSI Clusters and Sequence Logos
MUSI was used to cluster sequences from the round 5 samples [30] and then to generate sequence logos for
each cluster. The sequence logos for Axl and Mer round 5 clusters along with the size of each cluster are
shown in Tables 5.1 and 5.2. The remaining sequence logos are shown in Tables A.1 to A.5.
Table 5.1 shows that MUSI identified 10 clusters in sample F-Axl-5 (Table 5.1a). The C-terminal DY was
highly conserved across all clusters because the library F specification only allowed DY at the C-terminus.
Likewise, positions 12 and 13 were highly conserved across all clusters because the specification only allowed
A and G at position 12 and F, L, I, and M at position 13. Particularly striking was conservation of glycine
midway along the sequences (positions 6, 7, and 8) in clusters 2, 4, 9, and 11 (from the top).
For sample S-Axl-5 MUSI identified only 4 clusters (Table 5.1b). The C-terminal positions were less
conserved than in sample F-Axl-5 because the S library specification allowed more residues in these positions.
Salient features of the clustering included a conserved N-terminal YGSYY motif and a variable mid-region
followed by a low-complexity poly-Y, T, or L region.
For samples F-Mer-5 and S-Mer-5 MUSI identified 6 and 3 clusters, respectively (Table 5.2). In sample
F-Mer-5 (Table 5.2a) there was a prominent N-terminal YYPGS motif and sequences appear to be 17 residues
long on average. In sample S-Mer-5 (Table 5.2b), sequence length varied considerably, and there was a distinct
lack of consensus at the N-terminal half of the sequence.
5.1.2 Diversity over Panning Round
The number of distinct clones in each sample is shown in Figure 5.1. From this figure, one can see that
the diversity in each experiment trended downward over panning round, which agreed with basic principles
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Table 5.1: Sequence logos for clusters in samples F-Axl-5 and S-Axl-5. The first row in each table
shows the sequence logo for the entire sample. The column labelled “size” shows the number of distinct





















[40]. In library F the initial diversity (1.008 56× 105) was an order of magnitude greater than library S
(1.0801× 104); however, after the first round of panning, diversity in library F dropped significantly relative
to library S. The result of this drop was that, after round one, the diversity of the two libraries were nearly
identical.
The greater drop in library F diversity relative to library S may be explained by distinguishing sequence
diversity from functional diversity. Whereas sequence diversity is simply the number of distinct CDRH3
sequences, functional diversity only counts CDRH3 sequences that result in functional antibody fragments.
It is possible that the great drop in library F sequence diversity was an initial culling of non-functional clones
(e.g. clones expressing aberrant antibody fragments).
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Table 5.2: Sequence logos for clusters in samples F-Mer-5 and S-Mer-5. The first row in each table
shows the sequence logo for the entire sample. The column labelled “size” shows the number of distinct














Experiment S-Mer presents one exception to the general downward trend observed in Figure 5.1. Whereas
sequence diversity of most samples decreased by 2 orders of magnitude from rounds 1 to 5, the sequence
diversity of S-Mer decreased less than one order of magnitude. As a consequence, the sequence diversity of
S-Mer-5 is much higher than other round 5 samples. This result seems to contradict MUSI, which identified
only two clusters in S-Mer-5 (Table 5.2b). However, these observations are not necessarily incompatible
because the sequence logos in Table 5.2b show a lack of consensus in N-terminal half of the sequences, which
means that the clusters subsume a lot of the diversity in these regions.
5.1.3 Distribution of Physicochemical Properties
The physicochemical properties listed in Section 4.3 were calculated using the Peptides R package (version
1.1.1) [34]. Violin plots were created to show the distribution of physicochemical properties in each sample.
The most striking of these plots are shown in Figure 5.3. The rest of the plots can be found in Figures A.2
to A.5 of Appendix A. Figure 5.3 shows that there was a distinct trend to the distribution of some physico-
chemical properties. For example, aliphatic index trended upwards over panning rounds. In the same figure,
the length plot, which depicts the length distribution of distinct CDRH3 sequences, shows that the change in
length distribution over panning round was different for each target. Additionally it shows that, for the same
target, the change of the mean length was similar across libraries. These observations support the hypothesis























Figure 5.1: Log-scale bar graph of phage sample diversity over 5 rounds of panning for libraries F
and S. The panning round is shown on the x-axis and the logarithm of the number of unique clonal
sequences is shown on the y-axis. The red line running horizontally across each facet shows the initial





















Figure 5.2: Log-scale bar graph of phage sample diversity over 5 rounds of panning for libraries F
and S. The target is shown on the x-axis and the logarithm of the number of unique clonal sequences
is shown on the y-axis. The red line running horizontally across each facet shows the initial library
diversity (round 0).
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cases, the length distribution in round 5 was multi-modal, suggesting that clones in round 5 had multiple
specificities.
The two clusters identified by MUSI in S-Jagged1-5 (Table A.1) seem to support the hypothesis that
two modes correspond to multiple specificities. The sequences in the first cluster identified by MUSI are
approximately 11 amino acids long (positions 2-12 in Table A.1b; position 1 largely absent), while the
sequences in the second cluster are approximately 6 amino acids long (positions 7-12 in Table A.1b). These
lengths, 6 and 11, are the approximate modes of the length distributions shown in Appendix A.3.
The Wilcoxon ranked-sum test was used in conjunction with the Bonferroni correction to test the hy-
pothesis that the median X in round 0 is not equal to round 5, where X was one of the physicochemical
properties described in Section 4.3.3. The test found that, using a significance level of 0.01, the null hypoth-
esis was rejected for the following physicochemical properties: aliphatic index (p = 6.914× 10−5), Boman
index (p < 2.2× 10−16), instability index (p < 2.2× 10−16), length (p < 2.2× 10−16), and molecular weight
(p < 2.2× 10−16). Rejecting the null hypothesis meant that the difference of the median X between round
0 and 5 was statistically significant and, therefore, that panning selected clones with different median values
of X than those clones present in either library F or library S. The conclusion is that these physicochemical
properties have a statistically significant effect on clone outcomes.
5.2 Predicting Persistent Clones
5.2.1 Feature Selection
A total of 413 features were calculated from each CDRH3 sequence. These features were made up of 8
physicochemical properties, 20 amino acid compositions, and 384 dipeptide counts. A subset of these features
were selected for inclusion in the machine learning datasets. The motivation and method for selecting these
features was laid out Section 4.4.3. The selected features contained the following 20 features: aliphatic index;
bowman index; charge; molecular weight; isoelectric point; the relative frequency of amino acids C, D, L,
and S; and the absolute frequency of dipeptides DY, ER, LG, LL, LR, NW, QA, QG, QS, TT, and VL.
5.2.2 Cross-Validation
As explained in Section 4.4, a panel of five classifiers was trained on the feature-reduced datasets arising from
Section 5.2.1. The task was to classify clones as persistent or transient based on their CDRH3 sequence.
The panel consisted of a random forest (RF), artificial neural network (ANN), logistic model (LM), support
vector machine with an RBF kernel (SVM), and naive Bayes Network (NB).
The feature-reduced dataset arising from Section 5.2.1 was divided into 14 datasets according to which
experiment the data had originated from (i.e. the library and target that were used). Each of these 14
datasets were then balanced by randomly down-sampling the negative dataset until its size was equal to the
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Figure 5.3: Violin plots of the length and aliphatic index across the set of distinct clones identified
in each sample. Within each facet of the grid, the area of the violins is held constant; however,
across facets, the area of the violins is proportional to the number of distinct clones identified in the
experiment (i.e. library-target combination). Horizontal lines within the violins show the 25%, 50%,
and 75% quantiles. The red line tracking across each series of violins shows the mean value in each
sample.
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Table 5.3: The number of datapoints in each balanced dataset.
size of the positive dataset. The size of the resulting datasets are shown in Table 5.3. Classifiers were then
trained and tested on each of these 14 balanced datasets using 10-fold cross-validation. The classification
accuracy was calculated for each left-out fold to estimate the performance of each classifier on unseen data.
Figure 5.4 shows the distribution of the accuracy achieved by each classifier-dataset pairing. The average
accuracy of each classifier on each of the datasets is shown in Table A.7.
Figure 5.4 shows that, with the exception of the LM and perhaps the NB, the accuracy achieved by the
classifiers was comparable. The best one appeared to be the random forest classifier. A one-tailed Wilcoxon
signed-rank test showed that, using a significance level of 0.05 (0.0125 with the Bonferroni correction), the
RF classifier is at least better than the LM (p = 7.5× 10−7) and NB (7.2× 10−4), but not necessarily better
than the ANN (0.047) or RBF-SVM (0.112). A similar test was carried out and confirmed that the LM was
the worst classifier (p = 8.4× 10−5, 1.7× 10−6, 6.8× 10−6, 7.5× 10−7, respectively).
Figure 5.5 shows a multi-faceted boxplot that compares the classification accuracy obtained on each
dataset. Seen in this figure is the poor performance of classifiers on the S-Mer dataset relative to the other
datasets. A one-tailed Wilcoxon signed-rank test failed to support this observation. In fact, because of the
small sample sizes, the Wilcoxon signed-rank test could not, theoretically, produce p-values low enough to
reject the null hypothesis because only the ranks of datapoints are considered, not the degree of difference. To
account for the degree of difference, a one-tailed t-test using a significance level of 0.05 (0.0038 after Bonferroni
correction) was used. The t-test revealed that, assuming a Gaussian distribution, the accuracies achieved
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Figure 5.4: Boxplots showing the distribution of the accuracy achieved with each classifier on each
of the 14 balanced datasets. The solid circles show outliers. The dotted line running across each plot
marks the classification accuracy of a random classifier.























































Figure 5.5: Boxplots showing the same thing as Figure 5.4, but with the subplots arranged by target
instead of classifier.
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on S-Mer were statistically lower than F-Axl (p = 8.0× 10−4), S-Axl (2.2× 10−4), F-Jagged2 (2.6× 10−5),
S-Jagged2 (1.9× 10−3), and F-Notch3 (3.0× 10−3), but not F-Jagged1 (0.058), S-Jagged1 (0.043), F-Mer
(9.3× 10−3), F-Notch1 (0.011), S-Notch1 (0.066), F-Notch2 (0.066), S-Notch2 (0.042), and S-Notch3 (0.033).
5.2.3 Improving ANN Performance
Artificial neural networks can be classified based on the structure of the network formed by their nodes and
edges. Feedforward ANNs (described in Section 2.4.5) have nodes organized into layers and edges connecting
one layer to the next. One simple way to vary the architecture of a feedforward ANN is by changing the
number of hidden layers in the network. Hidden layers were described in Section 2.4.5 and the specific
methodology in Section 4.5. The cross-validation procedure used for comparing the panel classifiers was used
to determine the affect of adding more hidden layers to the ANN. The accuracy was plotted in Figure 5.6.
















































Figure 5.6: Boxplots showing the performance of the artificial neural networks with 1, 2, and 3
hidden layers. The solid circles represent outliers. The dotted line running horizontally across each
plot marks the classification accuracy of a random classifier.
Looking at Figure 5.6, it appears that additional layers did not offer any noticeable improvement. The
hypothesis that the performance of any one of the ANNs was statistically different from another is rejected
by the Friedman test using a significance level of 0.05 (p = 0.095).
Across libraries, it appears that the only difference in accuracy occurred on the Mer dataset. Accuracy
for the library S Mer dataset was significantly worse than for the library F Mer dataset, and only slightly
better than the accuracy achieved with random classification.
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5.2.4 Optimizing SVM Parameters
As explained in Section 4.6.2, a gridsearch was used to tune the hyperparameters of the RBF-SVM and
SSK-SVM for the prediction task set out in Section 4.4.1. At each vertex of the grid the average classification
accuracy achieved using 10-fold cross-validation is shown in Figure A.1. The average accuracy at each vertex
across all datasets is shown in Figures 5.8a and 5.8b. In these figures, there appears to be a boundary on
each grid, past which classification accuracy drops significantly. From the averaged gridsearch results, the
parameters with the highest accuracy were used in all of the subsequent SVM analyses. Using this criteria,
the parameters chosen were C = 10 and γ = 1 for the RBF-SVM and n = 2 and λ = 0.6 for the SSK-SVM.
Of all the hyperparameters tested during gridsearch, the RBF-SVM hyperparameters γ = 1 and C = 10
resulted in the highest classification accuracy. As explained in Section 2.4.5, γ is a parameter of the RBF
and the RBF kernel acts as a similarity measure between vectors. The similarity measure is one that decays
exponentially as the distance between two vectors increases. Intuitively, the parameter γ is the sensitivity of
the similarity metric to small changes in the distance. For a large γ, the difference between two vectors is
multiplied giving a low measure of similarity. Conversely, for a small γ, the difference between two vectors is
scaled down leading to a higher measure of similarity. The affect on a RBF of changing the original γ = 0.01
to the tuned value γ = 1.0 is shown in Figure 5.9.
5.2.5 Comparing the Tuned SVMs to the Original Classifier Panel
Figure 5.10 shows that that the tuned SVMs (denoted by a trailing “(t)”) compared favourably with the
original classifiers; however, a Wilcox ranked-sum test on each pair of the top classifiers (ANN, RBF-SVM,
RF, RBF-SVM (t), and SSK-SVM (t)) failed to identify a statistically significant difference between the
median accuracies achieved within this group. The p-values for these tests are shown in Table 5.4. A p-value
less than 0.005 was required to reject the null hypothesis due to the Bonferroni correction. This corresponded
to a significance level of 0.05.
Figure 5.11 and Figure 5.12 shows more clearly the change in mean accuracy after switching from one
of the original classifiers to the tuned SVMs. Figure 5.11 shows that the tuned RBF-SVM has nearly the
same performance of the RBF-SVM with default parameters. Figure 5.12 shows that the SSK-SVM performs
better than the RBF-SVM in most cases and better than all of the classifiers on the Axl and Notch2 datasets.
The average accuracy of each classifier (including the tuned SVMs) on each of the datasets is also shown
in Table A.7.
5.2.6 Conclusions
For many of the machine learning methods used in this thesis, the input had to be in the form of a numerical
vector. It was found that extracting an array of CDRH3 chemical properties (i.e. the physicochemical, amino





































































































Figure 5.8: Average performance of the RBF- and SSK-SVM using different parameters.
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Figure 5.9: A comparison of the effect of the γ parameter on the RBF kernel when one of the vectors
is held at the origin. (Left) The value of the RBF kernel over two dimensions using the original setting
of γ = 0.01. (Right) The value of the RBF kernel over two dimensions using the tuned value of γ = 1.0.
The tuned value of γ is much more sensitive to the distance between vectors.
ANN RBF-SVM RF RBF-SVM (t) SSK-SVM (t)
ANN 1.00 0.96 0.09 0.55 0.29
RBF-SVM 0.96 1.00 0.22 0.70 0.25
RF 0.09 0.22 1.00 0.06 0.60
RBF-SVM (t) 0.55 0.70 0.06 1.00 0.16
SSK-SVM (t) 0.29 0.25 0.60 0.16 1.00
Table 5.4: p-values from the Wilcoxon ranked-sum test comparing pairs of classifiers. Only the
classifiers with the best classification accuracy were tested. None of the p-values were less than 0.005;
therefore, none of the tests rejected the null hypothesis.
with these machine learning tools. Moreover, it was determined that such an encoding retains information
that is useful for predicting clone persistence.
By comparing various machine learning models, ANNs, SVMs, and RFs were shown to be capable of
achieving classification accuracy significantly better than achieved by chance. Moreover, the difference in
accuracy between the models was not statistically significant. Any of these models are thus suitable candidates
for further study of machine learning applications to antibody phage display. The SSK-SVM, which accepts
sequences as input thus eliminating the need to choose a vector encoding scheme, are particularly well-suited
to this application domain.
5.3 Generalizing the SVM Models
The utility of a machine learning model hinges on its ability to predict data not observed in the training set.
This ability is called generality. To test the generality of the RBF- and SSK-SVM, the SVMs were trained
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Figure 5.10: Boxplots showing the performance comparison of tuned SVMs and the original classifier
panel.
on the library F experiments and tested on library S experiments, keeping the target constant between runs.
The hyperparameters of the SVMs were set to the optimal values determined by a gridsearch (Section 5.2.4).
The analysis was described further in Section 4.7. The classification accuracy of each trained SVM on the
testing datasets (i.e. library S data) is shown in Figure 5.13. This figure shows that the accuracy of all
trained SVMs was better than random assignment, which would achieve 50% accuracy.
5.3.1 RBF-SVM Versus SSK-SVM Accuracy on Library S
The difference in mean classification accuracy of the RBF- and SSK-SVM on the testing data is shown
in Figure 5.13. Across all targets, the median difference in classification accuracy of the SVMs was not
statistically significant because the 95% confidence interval spans 0 (M=1.0%, CI=[-14.8%, 11.0%]); however,
for certain targets, the performance diverged considerably. For example, with targets Axl and Notch2, the
performance of the RBF-SVM exceeded that of the SSK-SVM by 16.4% and 14.8%, respectively. Conversely,
for targets Jagged2 and Notch3, the performance of the SSK-SVM exceeded that of the RBF-SVM by 17.3%
and 10.1%, respectively. This shows that, a priori one does not know whether one SVM will perform better
than the other, but for a given target it may be the case that one SVM will perform significantly better than
the other.
5.3.2 Conclusions
Both the tuned RBF- and SSK-SVM were trained on library F data and tested on library S data. Both
models achieved testing accuracy significantly better than achieved by chance, showing that the RBF- and
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Figure 5.11: Improvement in accuracy after switching from a classifier in the original panel to the
RBF-SVM with optimal hyperparameters. Improvement is measured as the increase in classification
accuracy.
SSK-SVM are capable of generalizing to other libraries and could potentially be used to help non-experts in
selecting clones for further study.
5.4 Interpreting the SVM Parameters
After training the RBF-SVM and the SSK-SVM models on the library F dataset, the model parameters were
inspected in order to better understand the basis for their predictions. As explained in Section 2.4.5, the
goal of SVM training is to select a subset of the training data, called support vectors, and an equal number
of weights such that these weights and support vectors define the maximum-margin separating plane.
5.4.1 SSK-SVM
As explained in Section 4.8.2, the support vectors of the SSK-SVM model can be decomposed into their
underlying 400-component vectors (one per dipeptide). Each of these 400 components multiplied by the sup-
port vector weight contributes additively to the decision function when the input contains the corresponding
dipeptide as a subsequence. Thus, the 400-component support vectors multiplied by their weights can be
summed (component-wise) to get an overall term for each dipeptide that determines the impact of a dipep-
tide on the prediction outcome. The dipeptides that have contributions greater than 1.0 or less than -1.0 are
shown in Figure 5.17. All of the dipeptide contributions can be found in Table A.6.
For the trained SSK-SVM model, Figure 5.17 shows which dipeptides in a clonal sequence that have
a significant contribution to the class prediction and the sign (+/-) of that contribution. The dipeptides
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Figure 5.12: Improvement in accuracy after switching from a classifier in the original panel to the
























Figure 5.13: Accuracy of the trained RBF- and SSK-SVMs on the 7 library S datasets. The SVMs
in this analysis were trained only on the library F data.
observed in Figure 5.17 can be classified into 3 categories: (1) dipeptides with mostly negative contribution
across all targets, (2) dipeptides with mostly positive contribution across all targets, and (3) dipeptides whose
contribution is target-dependent (e.g. HG, AG, and VG). Unsurprisingly, the large majority of dipeptides
fall into the third category.
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Table 5.5 shows the dipeptides with the highest and lowest weights for the SVM-SSK trained on each
target dataset.
Both the Wilcoxon rank-sum test and t-test were performed on each of the seven contributions of each
dipeptide. Using a significance level of 0.05, and the Bonferroni correction, both tests rejected the claim that
the median contribution of any of the dipeptides across all targets (including those outside of the 7 studied
here) is greater than or less than 0.
5.4.2 RBF-SVM
The input to the RBF-SVM can be thought of a 20-component vector that contains the values of each of the
20 features selected in Section 4.4.3. To understand how the RBF-SVM classifies the input, only a pair of
features was considered at a time. For each pair of features x and y, the x and y range covered by all the
support vectors was divided into 10× 10 grid. Each vertex in the grid was then input to the RBF-SVM. The
corresponding output of the RBF-SVM are shown in the tileplots in Figures 5.14 to 5.16 and Figures A.6
to A.8. The tileplots resulting from this procedure can be viewed as 2-dimensional projections of the decision
function. A red tile indicates that the corresponding vector parameters are more likely to be associated with
the persistent label, according to the SSK-SVM. A blue tile denotes an association with the transient
label.
5.4.3 Conclusions
The tuned SVMs models that were trained on library F data were deconstructed to yield greater insight into
the basis for their predictions.
Figure 5.14 shows that the predictions of the RBF-SVMs were highly dependent on the molecular weight of
the CDRH3 sequences. Molecular weight is highly correlated with CDRH3 length; therefore, this observation
is consistent with a study by Bharathi noting CDRH3 length preferences of the seven targets studied in this
thesis [13].
Strong dependencies on the amino acid concentrations and dipeptide counts were also observed. For
example, in Figure 5.15b, the bottom left corner of the C-D facet is red, suggesting that CDRH3 sequences
with low C and low D amino acid concentrations were preferentially selected during panning. Albeit less
pronouned, the pattern in Figure 5.16a shows that predictions were sensitive to the LG dipeptide count, with
low counts generally preferred for prediction of persistent clones.
Figures 5.14 to 5.16 suggest that considering at least two variables simultaneously can be highly beneficial
for predicting clone persistence. For example, in Figure 5.14a, in the facet showing molecular weight and
charge, the tiles in the bottom left and bottom right corners are red, showing that a CDRH3 with a low or
high molecular weight (using a relative scale) is preferred, but only when the charge of that CDRH3 is low.
Figure 5.17 shows that some peptides (e.g. DY, GD, and ID) have mostly a positive contribution across


























Figure 5.14: RBF-SVM support vector projections for the physicochemical properties. Panels (a),
(b), (c), and (d) show the projections for the RBF-SVMs trained on datasets F-Axl, F-Jagged2, F-Mer,
and F-Notch3, respectively. In each facet, the dimension of the vertical axis is equal to the name of
the feature in that row of facets. Likewise, the dimension of the horizontal axis is equal to the name
of the feature in that column of facets. The range of each axis is from the minimum support vector






















Figure 5.15: RBF-SVM support vector projections for the amino acid compositions. Refer to Fig-


















































Figure 5.16: RBF-SVM support vector projections for the dipeptide counts. Refer to Figure 5.14 for
a description.
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Table 5.5: Dipeptides with the biggest contribution to each SSK-SVM model. The dataset used to
train the SSK-SVM model is shown in the top row.
Axl Jagged1 Jagged2 Mer
Dipep Weight Dipep Weight Dipep Weight Dipep Weight
SP −1.5505 GH −1.3492 AP −1.5584 PS −1.1571
AY −1.4057 SM −1.1722 GH −1.5152 YM −0.9283
HG −1.3518 YG −1.1051 DD −1.4967 PG −0.7832
AG −1.3415 FW −1.0176 SH −1.2213 SV −0.7051
YM −1.2585 YT −1.0072 FV −1.2193 YY −0.6474
GI 1.0953 AG 1.1856 ID 1.3375 GM 0.5203
PA 1.1276 HA 1.4545 WY 1.4020 PA 0.5426
PH 1.1357 VG 1.6149 HY 1.4633 GD 0.5853
WA 1.2419 FY 1.6241 VA 1.4663 WA 0.6054
PY 1.3257 AW 2.3992 YM 2.1515 WV 0.6275
Notch1 Notch2 Notch3
Dipep Weight Dipep Weight Dipep Weight
FS −0.7649 VY −0.7848 GA −1.4380
SW −0.5493 SF −0.7296 WL −0.6782
GA −0.5385 GY −0.5237 HH −0.6460
FD −0.5130 YD −0.5213 GL −0.6009
GF −0.4720 FD −0.5094 LF −0.5194
GD 0.9241 SV 0.7618 PS 1.3934
GG 0.9687 HW 0.7628 FA 1.4871
MD 1.0184 MD 0.8076 GS 1.5433
YG 1.0518 SA 0.8677 VS 1.6188






















































































































Figure 5.17: Dipeptide contributions for each of the 7 SSK-SVM models.
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the 7 targets. Additionally, Table 5.5 shows that each target has a unique set of dipeptides that contribute
positively and negatively to the predicted persistence of a clone. The dipeptides that contributed positively
for target Mer had contributions of less magnitude than the other targets.
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Chapter 6
Discussion & Future Work
6.1 Predicting Persistent Clones
This thesis focused on the task of predicting whether a naive clone from either library F or library S will still
be observed after 5 rounds of panning against one of the seven targets described in Section 2.2.4. The labels
persistent and transient were used to distinguish between these two possibilities.
6.1.1 Machine Learning Comparison
Initially, five different classifiers were trained to predict a clone as either persistent or transient based on
its CDRH3 sequence. These classifiers were a random forest (RF), artificial neural network (ANN), support
vector machine (SVM), logistic model (LM), and a naive Bayes network (NB). These five classifiers were
cross-validated using the steps set out in Section 4.4 and then compared on the basis of their classification
accuracy in Section 5.2.2. A multifaceted barplot of the classification accuracy with facets arranged by
classifier is shown in Figure 5.4 and by dataset in Figure 5.5.
Although ANN, RF, and SVMs all achieved similar accuracies, each classifier entailed different advan-
tages/disadvantages. For example, one advantage of the random forest was that little effort was required to
tune its hyperparameters because the random forest only had one hyperparameter: the number of decision
trees. Preliminary trials showed quite readily that using more than the default 100 decision trees did not
produce a noticeable improvement in accuracy. On the other hand, it was difficult to interpret the random
forest because it was made up of so many decision trees, each trained using a slightly different subset of the
data; therefore, each decision tree was different. Contrasting with the random forest, the artificial neural
network had many hyperparameters, including the number of hidden layers, the number of nodes per layer,
the activation function of each layer, the initial weights prior to training. The abundance of hyperparameters
could be viewed as an advantage or a disadvantage. It could be an advantage because the ability to customize
ANNs allows them to be applied to a variety of problems. It could also be a disadvantage because, a priori,
finding the structure that works best for a given problem has the potential to be a time-consuming process
of trial-and-error. One advantage that the SVMs had over the RF and ANN models was that, whereas the
outcome of ANN training depends on the initial parameter values and the outcome of RF training is random
by design, the outcome of SVM training is deterministic. That is, there is a single globally optimal solution
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which the training procedure is guaranteed to converge to. A disadvantage of the SVM is that there are a
limited number of practical kernel types, which imposes certain restrictions on the flexibility of SVMs.
From Figure 5.5, it is apparent that the average performance on the S-Mer dataset was significantly lower
than on other datasets. Perhaps the poor performance is related to the exceptional nature of the S-Mer
dataset noted in Section 5.1.1, Section 5.1.2, and Section 5.4.3 and the independent observation that S-Mer
failed to produce target-specific clones [13]. The lack of well-defined clusters in Section 5.1.1 suggests that,
contrary to other experiments, there were no learnable patterns in the S-Mer-5 CDRH3 sequences to begin
with.
6.1.2 Improving SVM Performance
The best hyperparameters for the SSK-SVM were determined by gridsearch to be n = 2 and λ = 0.6.
Intuitively, n and λ are the length of the substrings and the gap penalty, and are described further in
Section 2.4.5. The hyperparameter n = 2 meant that considering amino acid pairs gave the best performance.
The λ = 0.6 meant that for each additional gap between the two amino acids, the contribution was diminished
almost by half. It is interesting to note that when gapped matches were discounted (λ = 0), classification
accuracy decreased, meaning that accounting for gapped matches actually improved classification accuracy.
This finding is significant because it supports the use of the SSK over simpler methods that only consider
continuous stretches of amino acids, called k-mers [41].
6.2 Generalizing the Trained SVM Models
RBF- and SSK-models were trained on library F data and tested on library S data to determine the extent
to which the models can generalize to other libraries.
6.2.1 SVM Performance on Library S
Figure 5.13 shows accuracy of the RBF- and SSK-SVMs compared to the accuracy that would be achieved by
a random assignment of the persistent and transient labels. The figure shows that both SVMs surpassed
the accuracy that would be achieved by relying on chance by a significant margin. This result was encouraging
because, although library F and library S have similar CDRH3 specifications (see Table 2.1), a significant
portion of CDRH3 sequences in library S are exclusive to library S. More work needs to be done to determine
to what degree the machine learning models generalize to this exclusive portion.
Although only library S was used for testing, this result suggests that the SVMs trained on library F
generalize to other experiments using the same target. Assuming this to be true, these SVMs could be used
to select clones in experiments that use the same targets provided that the library specification and antibody
framework are similar. More testing is needed to verify this hypothesis and future work could focus on
cross-validating the accuracy of the trained SVMs on libraries other than F and S.
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Because library F experiments were more successful at isolating target-binding clones than library S
experiments, it is possible that the SVMs trained on library F could identify target-binding clones from
library S experiments that yielded no obvious candidates, and thus were deemed to have failed.
6.3 SVM Models to Library Recommendations
6.3.1 Features of the CDRH3 Sequences
The SSK-SVM function projections in Figure 5.14 show that there is a steep colour transition on most facets
involving molecular weight. The steep colour transition indicates that the classification of the SSK-SVM is
highly dependent on the molecular weight of the input vector. Stated another way, all else being equal, a
vector that falls in the blue region is more likely to be classified as persistent than a vector that falls in
the red region. The high dependence on CDRH3 molecular weight, which is highly correlated with CDRH3
length, is consistent with the effect that CDRH3 length was seen to have on the fate of clones [13].
If one were to use the tileplots in Figures 5.14 to 5.16 to design better CDRH3 sequences, one could
change the amino acids in the CDRH3 sequence such that the sequence properties fall further into the red
regions of the tileplots than the blue regions. For example, in Figure 5.14a, in the molecular weight versus
charge facet, the bottom left and bottom right corners are bright red while the rest is blue. To create a
focused antibody library for Axl, one might start with library F and modify it such that more clones have
low or high molecular weights, and low charge.
6.3.2 Dipeptide Compositions of the CDRH3 Sequences
The dipeptide contributions suggest a way to construct focused antibody libraries. For example, to focus
library F towards all seven targets, one might rework the library specification to increase the occurrence
of dipeptides that have mostly positive contributions towards the 7 targets and decrease the occurence of
dipeptides with mostly negative contributions towards the 7 targets. Further, to focus library F towards
just one of the seven targets, Axl for example, one might additionally increase and decrease the occurence of
dipeptides that contribute positively and negatively to Axl, respectively.
The reader may wonder whether any of the dipeptides with contributions mostly positive or mostly
negative might have similar effects across targets outside of the 7 studied in this thesis. Assuming the 7
targets studied in this thesis were a random sampling of all possible antibody phage display targets, this
hypothesis (i.e. that the median contribution of a dipeptide is greater than or less than 0) can be tested
with the Wilcoxon ranked-sum test. Unfortunately, the result in Section 5.4.1, which used the Bonferroni
correction, rejected this hypothesis.
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Admittedly, the Bonferroni correction is one of the most conservative methods for controlling error in a
multiple hypothesis test. Future work will try less sensitive methods, including the S˘ida´k procedure, Holm
procedure, and procedures that achieve greater sensitivity by accepting a proportion of false discoveries [42].
6.4 Relation to Other Work
The work of this thesis explored a niche application of machine learning that has received little to no attention
in the scientific community. Although attempts to consolidate and make sense of phage display data is not a
new concept (bioinformatics applications to phage display has been reviewed by Huang et al. [43]), the vast
majority of work applies to general peptide phage display, as opposed to antibody phage display (i.e. display
of antibody fragments).
MimoDB 2.0 [44], a database containing peptides with known affinities for various targets, was considered
as an additional data source for the machine learning pipeline of this thesis; however, very few antibodies
were stored in this database; and of those antibodies, the listed target was different from the 7 targets of this
thesis. Future work could focus on creating a database similar in principal to MimoDB, but focused toward
antibody fragments. If such a database were developed, the information could be used to train and validate
future iterations of the machine learning pipeline presented of this thesis.
Another bioinformatics tool applicable to phage display is called SAROTUP [45]. The goal of SAROTUP
is to identify peptides in phage display experiments that contain motifs known to bind contaminants, reagents,
and substrates commonly encountered in phage display. These peptides are called target-unrelated peptides
because they can become enriched during panning and can therefore be mistaken for true target-binding
peptides. SAROTUP was considered for use in the pipeline presented in this thesis, but SAROTUP was
designed with general peptide phage display in mind as opposed to antibody phage display, and given the
highly structured nature of the antibody variable region (i.e. 6 loops from two different chains form the
final binding surface), it was decided that using sequence patterns with no consideration of antibody-specific
structure was not conducive to identifying target-unrelated antibodies.
A search for existing applications of machine learning to antibody phage display turned up only one
result, a technology called Abtracer. Abtracer is a data-driven technology owned by the company Molcure.
Unfortunately, the Molcure website provides no citations to papers describing the construction or validation of
the Abtracer pipeline [46]—possibly due to the proprietary nature of the technology. Molcure does, however,
provide a sketch of the pipeline, which includes the extraction of over 400 features (only molecular weight,
isoelectric point, and amino acid composition are explicitly listed), and developing classifiers via SVMs,
random forests, and deep neural networks (i.e. a many-layered artificial neural network).
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6.5 Training Data Quantity and Quality
The amount of training data used for training the machine learning models is shown in Table 5.3. The size
of the training dataset was deemed suitable for machine learning methods with a low to moderate number
of parameters, like the models used in this thesis. Using complex models with many parameters would have
lead to overfitting during training.
Some of the features that were extracted from the CDRH3 sequences were not independent of other
features (e.g. molecular weight and length were correlated). The CFS routine, which was used for fea-
ture selection, attempted to exclude correlated features so that the selected subset of features were nearly
independent.
6.6 Contributions
There are several potential uses for the classifiers that were developed in this thesis. The first potential use
is in selecting clones for further testing when the most abundant clones were found to be unsuitable (e.g. the
clones were target-unrelated, or they lost their binding ability when converted to full antibody molecules).
Whereas clone abundance is the first criteria used by analysts for picking clones for further study, studies have
shown that in some situations, clone abundance correlated poorly with target affinity [47]. The classifiers
developed in this thesis consider only the properties of the clonal sequence; therefore, they can be used when
clone abundance does not appear to be a suitable criteria.
6.7 Future Work
The work presented here is a first step towards using artificial intelligence to understand the seemingly
chaotic patterns of clone enrichment in antibody phage display. There are a number of ways this work could
be extended.
6.7.1 Feature Selection
The set of features extracted from the CDRH3 sequence of a clone was not exhaustive; therefore, future
work could consider features outside of those used in this thesis, like secondary structure or the Kidera
factors [48], which were derived using principal component analysis and are therefore independent. Another
possible feature to include is the abundance of the clone in the naive library. Although including abundance
as a feature would make the prediction more library-dependent, it might improve the prediction accuracy
substantially. Further, methods beside CFS could be explored for selecting a subset of features to include in
the final machine learning dataset.
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6.7.2 Alternative Classification Models
Figure 5.4 and the statistical tests in Table 5.4 show that, with respect to classification accuracy, the difference
between the ANN, RBF-SVM, and RF was insignificant. Moreover, this result held after tuning the ANN
(with respect to the number of hidden layers) and the RBF-SVM, and adding the SSK-SVM to the classifier
panel. The similar accuracies of these classifiers suggest that improving classification accuracy beyond that
achieved in this thesis may require a drastically different approach. One such approach might be to consider
the structural characteristics of all six CDRs and the structural characteristics of the target. Since the six
CDRs interact with each other to form the surface that may or may not bind the target, these structures
are of paramount importance to the problem of predicting clone persistence. Unfortunately, the structure of
CDRs and the target will not be available in many cases, and to try to predict these structures from their
sequence encroaches on a very difficult problem in computational biology. An acceptable compromise may
be to predict coarse structural features of the CDRs and target (e.g. alpha helices, beta strands, or buried
residues) and use those features in a machine learning pipeline instead/in addition to the features used in
this thesis.
Another approach that could be the focus of future work is to use machine learning models with dedicated
inputs for each position of the CDRH3 sequence. One example of such a model is an ANN that has a set
of input nodes for each position of a CDRH3 sequence and instead of a node being set to a property of
the entire sequence, a node is set to a property of the amino acid at a particular position in the sequence.
Such an ANN could then learn position-dependent patterns in the CDRH3 sequences and maybe achieve
better classification accuracy than achieved in this thesis. In pursuing this future work, one would need to
consider the increased computational demand and potential for over-fitting that characterize models with
many parameters.
Another method for achieving increased classification accuracy are ensemble methods, methods that
combine multiple models to improve prediction performance. One simple ensemble method is called “majority
voting”. Majority voting combines the predictions of several models by selecting the prediction that is output
from a majority of the models. To implement a majority voting scheme with the classifiers developed in this
thesis, the clonal sequence would be input to each of the models in the ensemble and the prediction would
be the class that was predicted by a majority of the models [49].
6.7.3 Predicting Clone Abundance
The aim of this thesis was to predict the presence of absence of a clone after the fifth round of panning based
on the clonal sequence. A slightly different prediction task would be to predict the abundance of the clone
after the fifth round of panning.
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6.7.4 Target-Independent Method
Two variations on the methodology of this thesis could solve related problems of interest to antibody phage
display researchers. The first variation would involve combining the datasets from all the experiments and
training the machine learning models on the combined dataset. By training the models on all of the data,
the hypothesis would be that there are some general properties of sequences that relate to clone persistence,
independent of the target.
The second variation would use a dataset from an antibody phage display experiment that used no target.
By training models to predict clones that are observed after five rounds of panning against no target, the
models might learn properties of CDRH3 sequences that are characteristic of target-unrelated clones. With
such a model, target-unrelated clones could be filtered from the sequence outputs of future experiments.
6.7.5 Size of the Training Dataset
It would be interesting to also look at the correlation between the size of the training datasets and the
prediction performance of the models. In the case that there is a correlation between dataset size and
prediction performance, one could improve this work by increasing the size of the datasets used to train
the machine learning models. The number of sequences (i.e. datapoints) collected from an antibody phage
display experiment is limited by the sequencing technology and protocol used for sequencing. More sequences
could be obtained by increasing the sequencing depth of a single sample. A more labour-intensive approach
to increasing the number of sequences would be to perform replicates of the same experiment.
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Table A.1: Sequence logos for clusters in samples F-Jagged1-5 and S-Jagged1-5. The first row in each
table shows the sequence logo for the entire sample. The column labelled “size” shows the number of













Table A.2: Sequence logos for clusters in samples F-Jagged2-5 and S-Jagged2-5. The first row in each
table shows the sequence logo for the entire sample. The column labelled “size” shows the number of













Table A.3: Sequence logos for clusters in samples F-Notch1-5 and S-Notch1-5. The first row in each
table shows the sequence logo for the entire sample. The column labelled “size” shows the number of














Table A.4: Sequence logos for clusters in samples F-Notch2-5 and S-Notch2-5. The first row in each
table shows the sequence logo for the entire sample. The column labelled “size” shows the number of














Table A.5: Sequence logos for clusters in samples F-Notch3-5 and S-Notch3-5. The first row in each
table shows the sequence logo for the entire sample. The column labelled “size” shows the number of















































































































Figure A.1: Tileplots showing the cross-validated classification accuracy for (left) the RBF-SVM and
(right) the SSK-SVM.
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A.3 Physicochemical Property Distributions









































Figure A.2: Violin plots showing the distribution of the aliphatic and Boman indices across the set
of distinct clones identified in each sample. Refer to Figure 5.3 for a description.
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Figure A.3: The distribution of the charge and hydrophobicity across the set of distinct CDRH3
sequences identified in each sample. Refer to Figure 5.3 for a description.
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Figure A.4: The distribution of the instability index and isoelectric point across the set of distinct
CDRH3 sequences identified in each sample. Refer to Figure 5.3 for a description.
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Figure A.5: The distribution of the length and molecular weight across the set of distinct CDRH3
sequences identified in each sample. Refer to Figure 5.3 for a description.
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Figure A.6: RBF-SVM support vector projections for the physicochemical properties. Panels (a),
(b), and (c) show the projections for the RBF-SVMs trained on datasets F-Jagged1, F-Notch1, and
F-Notch2, respectively. In each facet, the dimension of the vertical axis is equal to the name of the
feature in that row of facets. Likewise, the dimension of the horizontal axis is equal to the name of the
feature in that column of facets. The range of each axis is from the minimum support vector to the

















Figure A.7: RBF-SVM support vector projections for the amino acid compositions. Refer to Fig-






































Figure A.8: RBF-SVM support vector projections for the dipeptide counts. Refer to Figure 5.14 for
a description.
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A.5 SSK-SVM Dipeptide Contributions
Table A.6: Dipeptide contributions of the 7 SSK-SVM models.
Dip. Axl Jag1 Jag2 Mer Not1 Not2 Not3
AA 0.14 0.10 0.56 -0.01 0.45 0.17 0.34
AC -0.39 -0.08 -0.12 -0.22
AD -0.29 0.53 0.32 0.20 -0.19 0.66 1.12
AE -0.11 -0.01 0.02
AF 0.34 0.97 0.60 -0.17 -0.06 -0.32 0.37
AG -1.34 1.19 0.68 0.31 0.59 -0.26 0.85
AH 0.59 -0.06 0.06 0.22 -0.35 -0.44 0.84
AI -0.82 0.75 1.12 0.10 0.19 0.25 0.88
AL -0.75 0.50 0.45 0.16 -0.36 0.57 0.65
AM 0.05 -0.85 0.38 -0.10 0.67 0.65 -0.13
AN -0.22 0.07
AP 0.09 -0.47 -1.56 0.02 0.61 0.29 0.43
AR -0.01 -0.25 -0.01 -0.14
AS 0.79 -0.71 0.61 -0.31 0.07 -0.50 2.32
AT -0.19 -0.25 -0.07 -0.06 -0.03 -0.23
AV -0.32 0.58 -0.24 0.33 0.19 -0.22 0.42
AW -0.67 2.40 -0.64 0.35 0.27 -0.34 -0.52
AY -1.41 -0.57 0.95 0.35 0.36 0.72 0.74
CA -0.03 -0.33 -0.02 -0.01 -0.04
CC -0.11 -0.03
CD -0.65 -0.45 -0.11 -0.01 -0.05 -0.00 -0.00
CF 0.02 -0.18 -0.05 -0.32 -0.02
CG 0.11 -0.00 -0.00 -0.18 -0.01
CH 0.01 -0.03 -0.02
CI -0.00 -0.00
CL -0.06 -0.09 -0.05 -0.06 -0.14 -0.01
CM -0.59 -0.06 -0.19 -0.01 -0.00
CP -0.03 -0.03
CR -0.00 -0.01
CS -0.06 -0.05 -0.31 -0.04
CT -0.02
CV -0.05 -0.11 -0.00 -0.01 -0.08 -0.00
CW 0.03 -0.15 -0.03 -0.05
CY -0.39 -0.42 -0.41 -0.17 -0.33 -0.06 -0.07
DA 0.08 -0.22 -0.94
DC -0.02
DD 0.02 -0.08 -1.50 -0.01 -0.02
DF -0.03 0.10 -0.10 -0.03




DM -0.01 -0.13 -0.35
DN 0.36
DS -0.36 -0.08 -0.05 -0.22
DW 0.01 -0.05 -0.13
DY 0.60 0.49 1.31 0.50 0.47 0.42 0.95
EL -0.02
EY -0.16 0.03
FA -0.47 0.47 0.68 0.12 0.03 0.32 1.49
Dip. Axl Jag1 Jag2 Mer Not1 Not2 Not3
FC -0.13 -0.33 -0.21 -0.05 -0.04
FD 0.92 0.53 1.23 -0.30 -0.51 -0.51 -0.07
FF -0.85 0.61 -0.43 -0.12 0.29 0.62 0.22
FG 0.12 0.04 -0.01 0.45 0.25 0.64 0.33
FH 0.65 -0.30 -0.47 0.13 -0.42 0.04
FI 0.03 -0.20 -0.27 0.02 -0.05 -0.21
FL 0.03 -0.29 -0.39 -0.18 0.03 0.17 0.60
FM -0.00 -0.02 0.06 0.15 0.25 0.24 0.59
FN 0.00 -0.10 -0.04
FP 0.49 -0.80 0.04 0.04 0.22 0.17 0.16
FR -0.15 -0.01
FS 1.00 0.57 0.14 -0.08 -0.76 0.42 0.41
FT -0.03 -0.02 -0.05 -0.10 -0.10
FV -0.17 0.25 -1.22 -0.01 -0.18 -0.13 0.06
FW 0.14 -1.02 -0.44 0.20 0.83 0.06 0.33
FY 0.40 1.62 0.15 -0.07 0.50 0.43 0.92
GA 0.80 -0.18 0.48 -0.56 -0.54 -0.27 -1.44
GC -0.02 -0.08 -0.22 -0.02 -0.24 -0.37 -0.07
GD 0.81 1.06 0.95 0.59 0.92 0.47 0.03
GE 0.00
GF 0.19 0.50 0.64 0.08 -0.47 0.21 0.02
GG -0.34 0.19 0.24 0.26 0.97 0.08 0.45
GH 0.55 -1.35 -1.52 0.14 0.17 -0.16 0.86
GI 1.10 0.85 0.23 0.21 0.54 0.09 0.05
GK -0.25
GL -0.34 0.68 0.12 0.15 -0.13 0.00 -0.60
GM 0.50 0.44 0.01 0.52 0.72 0.08 0.47
GN 0.15 -0.06 0.17 -0.22
GP -1.12 0.65 0.10 -0.19 0.24 0.19 0.31
GQ -0.40
GR -0.11 -0.06 -0.52 -0.00 -0.11
GS 0.11 1.04 0.43 -0.58 -0.02 -0.24 1.54
GT -0.04 -0.47 -0.11 -0.02 -0.27 -0.26
GV -0.04 -0.06 0.56 0.10 0.19 -0.26 0.93
GW -1.09 -0.08 0.88 0.42 0.17 0.18 0.46
GY 0.43 0.39 -0.07 0.28 -0.20 -0.52 0.94
HA 0.05 1.45 0.34 0.24 0.40 0.18 -0.34
HC -0.02 -0.09
HD 0.21 0.21 0.06 -0.01 -0.04 0.12 0.07
HF 0.04 -0.19 0.11 0.06 -0.28 -0.06 -0.09
HG -1.35 0.07 0.83 0.04 -0.14 1.50 0.18
HH -0.11 0.43 0.50 0.05 0.15 0.19 -0.65
HI 0.10 0.15 0.67 0.04 0.43
HL 0.01 -0.02 -0.38 0.01 -0.10 0.20 0.13
HM 0.49 0.58 -0.06 0.02 0.13 0.01 -0.28
HP -0.17 -0.55 0.53 -0.24 0.24 0.19 0.91
HR -0.09
HS -0.59 -0.88 -0.89 0.44 0.06 -0.50 -0.37
HT -0.00 -0.01
HV -0.11 0.56 0.74 0.07 -0.13 0.15 0.07
HW -0.02 -0.43 -0.52 -0.06 -0.34 0.76 -0.45
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Table A.6 (cont.): Dipeptide contributions of the 7 SSK-SVM models.
Dip. Axl Jag1 Jag2 Mer Not1 Not2 Not3
HY -0.15 0.98 1.46 0.04 0.33 0.03 0.08
IA -0.52 0.00 -0.02 0.22 0.00 0.01
IC -0.04
ID 0.15 1.09 1.34 0.24 0.49 0.57 0.99
IE 0.00
IF 0.03
IG 0.17 -0.27 -0.02 -0.07
IH -0.00 -0.11
II -0.01
IL -0.12 -0.07 -0.01 -0.05 0.00






IV -0.35 0.36 -0.13
IW 0.01 0.18











LA -0.33 -0.08 -0.39 -0.07 -0.04 -0.01 -0.00
LC -0.30 -0.63 -0.03 -0.05
LD 0.66 0.96 0.24 0.35 0.01 0.31 0.25
LF -0.06 -0.02 -0.08 -0.10 -0.14 -0.52
LG -1.15 -0.12 -0.58 -0.21 -0.12 -0.04 -0.13
LH -0.01 -0.15 -0.24 -0.06 -0.00
LI -0.03 -0.34 -0.04 -0.21 -0.01
LL -0.57 -0.58 -0.26 -0.54 -0.12 -0.02 -0.02
LM -0.20 -0.06 -0.15 -0.11 -0.00
LN 0.22
LP -0.54 -0.22 -0.05
LR -0.15 -0.03 -0.36 -0.22 -0.02 -0.21
LS -0.75 -0.13 -0.26 -0.25 -0.05 -0.06
LT -0.49 -0.01 -0.27 -0.01 -0.01
LV -0.19 -0.52 -0.44 -0.05 -0.02 -0.21 -0.12
LW -1.07 -0.71 -0.26 -0.00 -0.08 -0.04
LY -1.01 -0.10 -0.44 0.10 -0.12 0.17 -0.15
MA -0.30 -0.22
MC -0.11 -0.13
MD -0.31 -0.09 0.07 0.15 1.02 0.81 0.40
ME -0.16 -0.02 0.03
MF -0.04 -0.36 -0.04
Dip. Axl Jag1 Jag2 Mer Not1 Not2 Not3
MG -0.18 -0.28 -0.23 -0.10
MI -0.01 -0.36













NY 0.08 -0.11 -0.36 0.23 -0.36
PA 1.13 -0.41 -0.24 0.54 0.51 0.23 1.08
PC -0.05 -0.01
PD -0.08 0.33 -0.07 0.07 0.26 0.20 0.27
PE 0.01
PF -1.12 -0.31 0.12 -0.06 0.55 0.16 0.36
PG -0.58 0.31 0.32 -0.78 0.56 0.67 0.68
PH 1.14 0.27 -0.65 -0.02 0.30 -0.04
PI 0.09 0.03 0.42 -0.00 0.01 0.08
PL -0.61 0.62 -0.12 -0.03 0.22 0.18 0.14
PM 0.13 -0.43 0.39 0.09 0.14 0.03 -0.03
PN 0.01
PP 0.69 0.18 -0.65 0.03 0.01 0.41
PR -0.03 -0.03 -0.00
PS 0.08 0.19 0.33 -1.16 0.66 0.57 1.39
PT -0.25 -0.04 -0.01
PV 1.01 -0.52 0.56 -0.09 0.26 0.64
PW -0.77 0.13 0.96 0.12 0.65 0.06 -0.03
PY 1.33 0.60 1.17 0.36 0.20 0.30 0.59
QA -0.40 -0.02
QC -0.04







QY -0.09 -0.01 -0.01
RA -0.31 -0.00 -0.55 -0.03
RC -0.05
RD -0.22 -0.03 -0.59 -0.06 -0.01 -0.21
RF -0.01 -0.07 -0.20 -0.16 -0.01 -0.22




Table A.6 (cont.): Dipeptide contributions of the 7 SSK-SVM models.
Dip. Axl Jag1 Jag2 Mer Not1 Not2 Not3
RK -0.15
RL -0.42 -0.04 -0.06 -0.05 -0.13
RM -0.30 -0.04 -0.16 -0.10
RP -0.17 -0.03
RR -0.01 -0.02
RS -0.04 -0.19 -0.43 -0.15 -0.02
RT -0.09 -0.01
RV -0.15 -0.07 -0.02 -0.36
RW -0.21 -0.02 -0.50 -0.00
RY -0.20 -0.04 -0.17 -0.10 -0.00 -0.12
SA 1.00 1.07 0.77 0.16 0.01 0.87 0.84
SC -0.64 -0.07 -0.14 -0.08 -0.08 -0.01
SD 0.58 -0.84 0.12 0.21 -0.36 0.32 0.21
SE -0.04 -0.01
SF 0.02 -0.34 1.04 0.22 -0.06 -0.73 0.45
SG -0.30 -0.21 0.61 0.36 1.13 0.75 0.62
SH 0.72 -0.61 -1.22 0.17 0.58 0.24 1.04
SI 0.24 0.74 0.40 0.01 0.24 0.22 0.20
SK -0.41
SL 0.24 -0.63 -0.01 -0.08 -0.20 0.16 0.39
SM -0.60 -1.17 -0.63 0.05 -0.07 0.42 -0.05
SN 0.36 0.08 -0.17 0.08
SP -1.55 0.10 0.65 -0.05 0.12 0.26 -0.45
SR -0.33 -0.02 -0.40 -0.03 -0.02
SS 0.61 -0.04 0.87 0.07 0.90 0.31 0.08
ST -0.02 -0.38 -0.06 -0.19 -0.00 -0.02
SV 0.32 -0.25 -0.21 -0.71 0.57 0.76 0.28
SW 0.00 -0.74 0.19 0.06 -0.55 0.03 0.25
SY -1.01 -0.05 -0.30 -0.11 0.38 -0.44 -0.20
TA -0.33 -0.70 -0.35 -0.00 -0.25 -0.02 -0.13
TC -0.08 -0.01
TD -0.27 -0.50 -0.22 -0.12 -0.04 -0.12 -0.01
TF -0.00 -0.13 -0.05 -0.01 -0.02
TG -0.27 -0.09 -0.21 -0.02 -0.15 -0.06
TH -0.03 -0.04
TI -0.26 -0.33 -0.02 -0.16
TK -0.05
TL -0.51 -0.21 -0.17 -0.05 -0.18
TM -0.17 -0.09 -0.02 -0.13 -0.06 -0.16
TP -0.01 -0.16
TR -0.09 -0.15 -0.36
TS -0.10 -0.06 -0.24 -0.02
TT -0.06 -0.28 -0.04 -0.01
TV -0.02 -0.26 -0.06 -0.00 -0.12 -0.22
TW -0.19 -0.26 -0.03 -0.22
TY 0.07 -0.31 -0.14 -0.07 -0.03 -0.20 -0.01
VA 1.03 0.55 1.47 -0.33 0.46 0.45 0.96
VC -0.10 -0.15 -0.05 -0.08
VD -0.07 0.10 -0.77 0.19 0.03 -0.23 -0.18
VF 0.36 0.13 -0.62 0.15 0.24 0.70 0.51
VG -1.05 1.61 0.75 -0.01 0.05 0.05 0.48
Dip. Axl Jag1 Jag2 Mer Not1 Not2 Not3
VH 0.55 0.21 1.23 0.02 0.10 0.25 -0.51
VI -0.22 0.24 -0.82 0.04 0.06 -0.15 -0.15
VK -0.09
VL -0.35 -0.18 0.51 -0.30 -0.04 -0.26 -0.18
VM 0.13 0.72 0.10 0.23 0.14 -0.39 0.18
VN -0.28 0.04 -0.13
VP -0.13 -0.39 -0.06 0.01 0.20 0.21 0.00
VR -0.19 -0.26 -0.01 -0.01 -0.14
VS 0.38 0.76 -0.18 -0.13 0.34 0.23 1.62
VT -0.01 -0.01 -0.06 -0.25 -0.26
VV 0.19 0.28 -0.83 -0.02 0.25 0.58 0.64
VW -0.55 1.06 0.68 0.22 -0.13 0.34 0.16
VY 0.58 0.91 -0.89 0.40 0.26 -0.78 0.07
WA 1.24 0.75 -0.61 0.61 0.56 0.64 0.97
WC -0.13 -0.07 -0.19 -0.08 -0.14 -0.02
WD 0.04 -0.04 0.35 -0.03 0.14 -0.03 -0.08
WE -0.00
WF -0.03 -0.64 -0.47 0.24 0.38 -0.15 0.58
WG -0.10 0.30 0.53 -0.31 -0.07 -0.07 0.54
WH 0.31 -0.33 -0.22 0.20 -0.23 -0.43 0.13
WI -0.29 0.52 0.66 0.09 0.23 0.33
WL 0.00 -0.06 -0.74 -0.01 -0.20 -0.16 -0.68
WM -0.04 0.12 0.73 0.16 0.27 0.10 -0.19
WN 0.05
WP 0.68 -0.84 -0.83 -0.16 0.73 0.74
WQ -0.06
WR -0.30 -0.02 -0.08 -0.05
WS -0.05 0.09 -0.73 -0.10 0.09 0.29 -0.08
WT 0.15 -0.15 -0.19 -0.02
WV -0.04 -0.93 0.56 0.63 0.02 0.02 1.18
WW -0.44 0.80 -0.23 0.31 0.27 -0.36 0.34
WY 0.57 0.40 1.40 0.27 0.32 -0.31 0.02
YA -0.57 0.35 -0.45 -0.17 0.09 0.22 0.44
YC -0.26 -0.19 -0.06 -0.32 -0.01
YD -1.14 -0.33 1.27 -0.45 -0.10 -0.52 0.39
YE -0.08 -0.00 0.02
YF 0.77 0.10 0.08 -0.63 0.33 -0.11 0.84
YG 0.49 -1.11 0.03 0.20 1.05 0.45 0.41
YH 0.84 0.17 0.31 -0.16 -0.00 0.56 0.08
YI -0.47 0.02 0.37 -0.01 0.60 0.22 0.13
YL -0.08 0.37 -0.14 -0.07 0.33 -0.28 0.38
YM -1.26 0.79 2.15 -0.93 -0.09 0.32 -0.14
YN 0.04 -0.21 -0.01 -0.08
YP -0.09 -0.98 0.11 -0.27 0.66 0.03 -0.31
YQ -0.18 -0.21 -0.04
YR -0.08 -0.33 -0.38 -0.03
YS 0.35 -0.05 -0.01 0.39 0.37 0.31 0.41
YT -0.11 -1.01 -0.26 -0.21 -0.00 -0.04
YV 0.03 -0.51 0.22 0.10 0.79 0.42 0.99
YW 0.69 0.02 -0.60 -0.35 0.43 -0.17 0.47
YY 0.93 0.23 0.37 -0.65 0.14 0.29 1.12
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A.6 Average Classification Accuracies
Table A.7: The average classification accuracy of the compared machine learning models. The
accuracy was measured using 10-fold cross-validation.
Library Target Classifier Accuracy
F Axl NB 76.05
F Axl LM 65.79
F Axl ANN 78.68
F Axl RBF-SVM 81.32
F Axl RF 83.68
F Axl RBF-SVM (t) 75.00
F Axl SSK-SVM (t) 87.11
F Jagged1 NB 71.02
F Jagged1 LM 51.58
F Jagged1 ANN 70.98
F Jagged1 RBF-SVM 69.80
F Jagged1 RF 74.58
F Jagged1 RBF-SVM (t) 71.37
F Jagged1 SSK-SVM (t) 72.63
F Jagged2 NB 78.28
F Jagged2 LM 71.68
F Jagged2 ANN 81.38
F Jagged2 RBF-SVM 78.30
F Jagged2 RF 83.67
F Jagged2 RBF-SVM (t) 80.15
F Jagged2 SSK-SVM (t) 80.99
F Mer NB 78.53
F Mer LM 61.29
F Mer ANN 89.30
F Mer RBF-SVM 85.15
F Mer RF 91.69
F Mer RBF-SVM (t) 88.71
F Mer SSK-SVM (t) 92.83
F Notch1 NB 85.44
F Notch1 LM 60.82
F Notch1 ANN 93.13
F Notch1 RBF-SVM 92.36
F Notch1 RF 93.08
F Notch1 RBF-SVM (t) 93.08
F Notch1 SSK-SVM (t) 89.40
F Notch2 NB 78.68
F Notch2 LM 51.98
F Notch2 ANN 76.37
F Notch2 RBF-SVM 67.25
F Notch2 RF 83.30
F Notch2 RBF-SVM (t) 71.81
F Notch2 SSK-SVM (t) 87.97
F Notch3 NB 82.27
F Notch3 LM 65.45
F Notch3 ANN 88.86
F Notch3 RBF-SVM 87.27
F Notch3 RF 90.23
F Notch3 RBF-SVM (t) 89.32
F Notch3 SSK-SVM (t) 89.55
Library Target Classifier Accuracy
S Axl NB 71.04
S Axl LM 77.76
S Axl ANN 79.53
S Axl RBF-SVM 82.15
S Axl RF 84.21
S Axl RBF-SVM (t) 79.24
S Axl SSK-SVM (t) 88.31
S Jagged1 NB 58.64
S Jagged1 LM 55.73
S Jagged1 ANN 79.64
S Jagged1 RBF-SVM 73.82
S Jagged1 RF 74.82
S Jagged1 RBF-SVM (t) 68.36
S Jagged1 SSK-SVM (t) 76.82
S Jagged2 NB 76.43
S Jagged2 LM 64.45
S Jagged2 ANN 83.02
S Jagged2 RBF-SVM 85.51
S Jagged2 RF 89.95
S Jagged2 RBF-SVM (t) 77.96
S Jagged2 SSK-SVM (t) 91.17
S Mer NB 61.20
S Mer LM 56.00
S Mer ANN 62.40
S Mer RBF-SVM 58.40
S Mer RF 60.80
S Mer RBF-SVM (t) 60.60
S Mer SSK-SVM (t) 55.60
S Notch1 NB 79.03
S Notch1 LM 62.78
S Notch1 ANN 84.44
S Notch1 RBF-SVM 91.67
S Notch1 RF 90.69
S Notch1 RBF-SVM (t) 86.81
S Notch1 SSK-SVM (t) 87.92
S Notch2 NB 66.96
S Notch2 LM 54.38
S Notch2 ANN 75.07
S Notch2 RBF-SVM 72.75
S Notch2 RF 82.91
S Notch2 RBF-SVM (t) 71.60
S Notch2 SSK-SVM (t) 84.12
S Notch3 NB 77.72
S Notch3 LM 52.11
S Notch3 ANN 90.96
S Notch3 RBF-SVM 94.15
S Notch3 RF 91.55
S Notch3 RBF-SVM (t) 90.96
S Notch3 SSK-SVM (t) 88.86
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